Document:

Exhibit 10.1

 

FORM OF STOCKHOLDERS AGREEMENT

 

 

 

Stockholders
AGREEMENT

 

BY AND AMONG

 

nci building
systems, Inc.,

 

Clayton,
Dubilier & Rice Fund VIII, L.P.,

 

CD&R
FRIENDS & FAMILY FUND VIII, L.P.,

 

CD&r
PISCES HOLDINGS, L.P.

 

GGC BP Holdings,
LLC

 

AIC Finance
Partnership, L.P.

 

and

 

Atrium Intermediate
Holdings, LLC

 

DATED
AS OF [●],
2018

 

 

 

 

 

 

     

     

    

TABLE OF CONTENTS

 

Page

 

ARTICLE I

DEFINITIONS

 

	Section 1.1	Certain Definitions	2
	 	 	 
	ARTICLE II
	REPRESENTATIONS AND WARRANTIES
	 
	Section 2.1	Representations and Warranties of the Company	13
	Section 2.2	Representations and Warranties of the CD&R Investors	13
	Section 2.3	Representations and Warranties of the Golden Gate Investor	13
	 	 	 
	ARTICLE III
	GOVERNANCE MATTERS; VOTING; STANDSTILL PROVISIONS
	 
	Section 3.1	Board of Directors	14
	Section 3.2	Voting	20
	Section 3.3	Standstill and Other Restrictions	21
	 	 	 
	ARTICLE IV
	TRANSFER AND HEDGING RESTRICTIONS
	 
	Section 4.1	Transfer Restrictions	22
	Section 4.2	Hedging Restrictions	24
	 	 	 
	ARTICLE V
	SUBSCRIPTION RIGHTS
	 
	Section 5.1	Subscription Rights	24
	Section 5.2	Notice	25
	Section 5.3	Purchase Mechanism	27
	Section 5.4	Failure to Purchase	28
	Section 5.5	Certain Qualified Offerings	28
	Section 5.6	Cooperation	29
	Section 5.7	Limitation of Rights	29
	Section 5.8	Termination of Subscription Rights	29
	 	 	 
	ARTICLE VI
	CONSENT RIGHTS
	 
	Section 6.1	CD&R Investor Consent Rights	29

 

 

     

     

    

 

	 	 	 
	ARTICLE VII
	EFFECTIVENESS AND TERMINATION
	 
	Section 7.1	Termination	31
	 	 	 
	ARTICLE VIII
	ACCESS, INFORMATION AND CONFIDENTIALITY
	 
	Section 8.1	Confidentiality	31
	Section 8.2	Access and Information	32
	 	 	 
	ARTICLE IX
	MISCELLANEOUS
	 
	Section 9.1	Tax Matters.	33
	Section 9.2	Successors and Assigns	33
	Section 9.3	Amendments; Waiver; Company Action; CD&R Investor Obligations	34
	Section 9.4	Notices	35
	Section 9.5	Governing Law	36
	Section 9.6	Specific Performance; Jurisdiction	36
	Section 9.7	Waiver of Jury Trial	37
	Section 9.8	Headings	38
	Section 9.9	Entire Agreement	38
	Section 9.10	Severability	38
	Section 9.11	Counterparts	38
	Section 9.12	Interpretation	38
	Section 9.13	No Third Party Beneficiaries	38
	Section 9.14	Investor Portfolio Companies	39
	Section 9.15	Conflicting Agreements	39
	Section 9.16	Termination of 2009 Stockholders Agreement	40

 

 

    	 	- ii -	 

     

    

 

THIS STOCKHOLDERS AGREEMENT (this “Agreement”),
dated as of [●], 2018, is made by and among NCI Building Systems, Inc., a Delaware corporation, Clayton, Dubilier & Rice
Fund VIII, L.P., a Cayman Islands exempted limited partnership (“CD&R Fund VIII”), CD&R Friends &
Family Fund VIII, L.P., a Cayman Islands exempted limited partnership (“CD&R FF Fund VIII”), CD&R Pisces
Holdings, L.P., a Cayman Islands exempted limited partnership (“CD&R Pisces”), and Atrium Intermediate Holdings,
LLC, a Delaware limited liability company (“Atrium”), and GGC BP Holdings, LLC, a Delaware limited liability
company, and AIC Finance Partnership, L.P., a Cayman Islands exempted limited partnership (“AIC” and, together
with Atrium and GGC, the “Golden Gate Investor Group,” and each of Atrium, AIC and GGC, a “Golden Gate
Investor”). Each of CD&R Fund VIII, CD&R FF Fund VIII and CD&R Pisces is sometimes referred to herein as
a “CD&R Investor” and, collectively, as the “CD&R Investor Group.” The Golden Gate
Investor Group and the CD&R Investor Group are collectively referenced herein as the “Investors.”

 

W I T N
E S S E T H:

 

WHEREAS, the Company (as herein defined) and
CD&R Fund VIII entered into an Investment Agreement, dated August 14, 2009, pursuant to which the Fund VIII CD&R Investors
(as defined herein) purchased and acquired from the Company, and the Company issued and sold to the CD&R Fund VIII Investors,
shares of a newly created series of preferred stock designated the Series B Cumulative Convertible Participating Preferred Stock,
par value $1.00 per share of the Company (the “Series B Preferred Stock”), which was convertible into shares
of Common Stock, par value $.01 per share of the Company (the “Common Stock”);

 

WHEREAS, as of the date of this Agreement,
there is no Series B Preferred Stock issued or outstanding, and the CD&R Fund VIII Investors hold shares of Common Stock previously
issued upon the conversion of Series B Preferred Stock;

 

WHEREAS, the Company, CD&R Fund VIII and
CD&R FF Fund VIII entered into that certain Stockholders Agreement, dated October 20, 2009 (the “2009 Stockholders
Agreement”);

 

WHEREAS, the Company, CD&R Fund VIII and
CD&R FF Fund VIII wish to terminate the 2009 Stockholders Agreement upon entry into this Agreement;

 

WHEREAS, the Company, Ply Gem Parent, LLC,
a Delaware limited liability company, and Clayton, Dubilier & Rice, LLC entered into an Agreement and Plan of Merger, dated
17, 2018 (as it may be amended from time to time, the “Merger Agreement”), pursuant to which CD&R Pisces
and each Golden Gate Investor were issued shares of Common Stock; and

 

WHEREAS, the Investors and the Company desire
to set forth certain terms and conditions regarding the Investors’ ownership of Common Stock, including certain restrictions
on the Transfer (as defined herein) of Common Stock and on certain actions of the Investors and their Affiliates with respect to
the Company, and to provide for, among other things, subscription rights, corporate governance rights and consent rights, and other
obligations and rights;

 

NOW, THEREFORE, in consideration of the premises
and of the respective representations, warranties, covenants and conditions contained herein, the parties hereto agree as follows:

 

     

     

    

 

ARTICLE
I

DEFINITIONS

 

Section 1.1Certain Definitions.
In addition to other terms defined elsewhere in this Agreement, as used in this Agreement, the following terms shall have the meanings
ascribed to them below. All terms used and not defined in this Agreement shall have the meanings assigned to them in the Merger
Agreement.

 

“10% Holder” shall mean
a Person or Group Beneficially Owning securities of the Company entitling such Person or Group to cast a number of votes in excess
of 10% of the Aggregate Voting Power.

 

“2009 Stockholders Agreement”
shall have the meaning set forth in the Recitals hereto.

 

“ABL Credit Agreement”
shall mean that certain ABL Credit Agreement, dated as of April 12, 2018, among the Company (as successor by merger to Ply Gem
Midco, Inc., as parent borrower, the U.S. subsidiary borrowers from time to time party thereto, the Canadian borrowers from time
to time party thereto, the lenders and issuing lenders from time to time party thereto, UBS AG, Stamford Branch, as administrative
agent and collateral agent, and the other parties thereto, as the same may be amended, supplemented, waived or otherwise modified
from time to time.

 

“Affiliate” shall mean,
with respect to any Person, any other Person that directly, or through one or more intermediaries, controls or is controlled by
or is under common control with such Person. For purposes of this Agreement, “control” shall mean, as to any
Person, the power to direct or cause the direction of the management and policies of such Person, whether through the ownership
of voting securities, by contract or otherwise (and the terms “controlled by” and “under common control
with” shall have correlative meanings).

 

“Affiliate Transactions”
shall mean any transactions between the Company and its Controlled Affiliates, on the one hand, and any of the Investors or their
Affiliates (other than the Company and its Controlled Affiliates), on the other hand; provided that none of the following
shall constitute an Affiliate Transaction:

 

(i)       acquisitions
of securities, or payments, transactions, Board of Director rights, access rights, anti-dilution rights, registration rights, subscription
rights and the other matters governed by this Agreement, the Merger Agreement or the Registration Rights Agreement;

 

(ii)       customary
compensation arrangements (whether in the form of cash or equity awards), expense reimbursement, D&O insurance coverage, and
indemnification arrangements (and related advancement of expenses) in each case for CD&R Investor Directors and Board Observers;
or

 

    	 	- 2 -	 

     

    

 

(iii)       transactions
and arrangements in the ordinary course of business and on arm’s-length third-party terms with any portfolio company held
or managed by the CD&R Investor Group or the CD&R Parent Controlled Affiliate and not involving in excess of $4 million
per annum with respect to any such portfolio company and $20 million per annum with respect to all such portfolio companies.

 

“Aggregate Voting Power”
shall mean, as of any date, the number of votes that may be cast by all holders of Common Stock voting together as a single class
on any matter on which the holders of Common Stock are entitled to vote.

 

“Agreement” shall have
the meaning set forth in the preamble.

 

“Bankruptcy Exceptions”
shall have the meaning set forth in Section 2.1(c).

 

“Beneficially Own” shall
mean, with respect to any securities, having “beneficial ownership” of such securities for purposes of Rule 13d-3 or
13d-5 under the Exchange Act as in effect on the date hereof, and “Beneficial Ownership” shall have the corresponding
meaning; provided that (i) the CD&R Investor Group, the Golden Gate Investor Group and their respective Affiliates shall
not be deemed to “Beneficially Own” any securities of the Company held or owned by any CD&R Investor Portfolio
Company or any Golden Gate Investor Portfolio Company, (ii) the CD&R Investor Group shall not be deemed to “beneficially
own” any securities of the Company held or owned by any member of the Golden Gate Investor Group and (iii) the Golden Gate
Investor Group shall not be deemed to “beneficially own” any securities of the Company owned by any member of the CD&R
Investor Group.

 

“Board” shall mean the
Board of Directors the Company.

 

“Board Observer” shall
have the meaning set forth in Section 3.1(c)(iii).

 

“Business Combination”
shall mean (i) any reorganization, consolidation, merger, share exchange, tender or exchange offer or other business combination
or similar transaction involving the Company with any Person or (ii) the sale, assignment, conveyance, transfer, exchange,
lease or other disposition (including by liquidation or dissolution of the Company) by the Company of all or substantially all
of its assets to any Person.

 

“Business Day” shall mean
any day other than a Saturday, Sunday or a legal holiday in New York City or Houston, or any other day on which commercial banks
in New York City or Houston are authorized or required by Law or government decree to close.

 

“By-laws” shall mean the
By-laws of the Company, as amended from time to time (subject to Section 6.1(a)(x)).

 

“Cash Flow Credit Agreement”
shall mean that certain Cash Flow Credit Agreement, dated as of April 12, 2018, among the Company (as successor by merger to Ply
Gem Midco, Inc.), as borrower, the several banks and other financial institutions from time to time party thereto and JPMorgan
Chase Bank, N.A., as administrative agent and collateral agent, as the same may be amended, supplemented, waived or otherwise modified
from time to time.

 

    	 	- 3 -	 

     

    

 

“CD&R Director” shall
mean any CD&R Nominee elected or appointed to the Board, from time to time, including, for the avoidance of doubt, the principals
or partners of CD&R Parent who are designated as such on Schedule 3.1(a) during such individual’s service on the Board.

 

“CD&R FF Fund VIII”
shall have the meaning set forth in the preamble.

 

“CD&R Fund VIII” shall
have the meaning set forth in the preamble.

 

“CD&R Investor Consent Action”
shall mean any of the actions of the Company requiring the consent of the CD&R Investor Group pursuant to ARTICLE VI.

 

“CD&R Investor Director”
shall mean any CD&R Investor Nominee who is elected or appointed to the Board.

 

“CD&R Investor Director Number”
shall mean a number of directors that is the lesser of (x) the number that is proportionate to the CD&R Investor Voting Interest,
rounded to the nearest whole number, and (y) the number that is one (1) less than the number of Independent Non-CD&R Investor
Directors at the relevant time.

 

“CD&R Investor Group”
shall have the meaning set forth in the preamble.

 

“CD&R Investor Independent Director”
shall mean any CD&R Investor Independent Nominee who is elected or appointed to the Board, from time to time, and the directors
on the Initial Board who are designated as such on Schedule 3.1(a).

 

“CD&R Investor Independent Nominee”
shall mean an individual who (i) is designated by the CD&R Investor Group in writing to the Company for election to the Board,
or is designated as a replacement director for appointment to the Board, pursuant to Section 3.1(c)(i) or Section 3.1(c)(ii) and
(ii) would be an Independent Director upon such individual’s appointment or election to the Board.

 

“CD&R Investor Nominee”
shall mean a CD&R Nominee, a CD&R Investor Independent Nominee or an Other CD&R Investor Nominee.

 

“CD&R Investor Portfolio Company”
shall mean any portfolio company of CD&R Parent or any of the CD&R Investors with respect to which neither CD&R Parent,
nor any CD&R Investor nor any of their respective Affiliates (excluding such portfolio company and its Controlled Affiliates)
exercises control over investment decisions with respect to the Company’s securities, or encouraged, influenced or facilitated
any such decision or action by such portfolio company with respect to the Company’s securities; provided that (a)
neither CD&R Parent, nor any of the CD&R Investors nor any of their respective Affiliates (excluding such portfolio company
and its Controlled Affiliates) shall provide or have provided to such portfolio company or any of its Controlled Affiliates any
non-public information concerning the Company or any Subsidiary of the Company, and (b) such portfolio company is not acting at
the request or direction of or in coordination with any of CD&R Parent, any CD&R Investor or any of their respective Controlled
Affiliates (excluding such portfolio company and its Controlled Affiliates) with respect to the Company’s securities.

 

    	 	- 4 -	 

     

    

 

“CD&R Investor Rights Period”
shall have the meaning set forth in Section 3.1(c)(i).

 

“CD&R Investor Rights Termination
Event” shall be deemed to have occurred if, at any time following the Closing Date, the CD&R Investor Voting Interest
is less than 7.50%.

 

“CD&R Investor Voting Interest”
shall mean, as of any date, with respect to the CD&R Investor Group, the ratio, expressed as a percentage, of (i) the aggregate
number of votes that may be cast by holders of Common Stock Beneficially Owned by the CD&R Investor Group at the relevant time,
divided by (ii) the Aggregate Voting Power at the relevant time.

 

“CD&R Investors” shall
have the meaning set forth in the preamble.

 

“CD&R Nominee” shall
mean a principal or partner of any of the CD&R Investors or CD&R Parent who is designated by the CD&R Investor Group
in writing to the Company as a nominee for election to the Board, or is designated as a replacement director for appointment to
the Board, pursuant to Section 3.1(c)(i) or Section 3.1(c)(ii).

 

“CD&R Parent” shall
mean any entity that is or performs the functions of, directly or indirectly, the managing member or general partner of any CD&R
Investor or is the investment manager with respect to such entity and all such entities collectively.

 

“CD&R Pisces” shall
have the meaning set forth in the preamble.

 

“CD&R Parent Controlled Affiliate”
shall mean CD&R Parent and any individuals that are partners, managing members or have similar titles with respect thereto,
together with the Controlled Affiliates of any of them or of any CD&R Investor or any entity with respect to which CD&R
Parent is the investment manager.

 

“CD&R Standstill Termination
Event” shall be deemed to have occurred on the last day of the first continuous six-month period during which the CD&R
Investor Voting Interest is less than 10.0%.

 

“Certificate
of Incorporation” shall mean the Company’s
Restated Certificate of Incorporation, as amended from time to time (subject to Section 6.1(a)(x)).

 

“Change
of Control” shall mean, with respect to the Company,
the occurrence of any one of the following events:

 

(i) any Person or Group (other
than the CD&R Investors and their Affiliates) hold or acquiring, directly or indirectly, a Voting Interest greater than 50%;

 

(ii) the consummation of a Non-Qualified
Business Combination; or

 

    	 	- 5 -	 

     

    

 

(iii) the number of directors
who are not Continuing Directors and who are nominated by any Person or Group (other than the CD&R Investors and their Affiliates)
constituting at least a majority of directors that would constitute the full Board if there were no vacancies.

 

“Change of Control Event”
shall mean a Change of Control has been consummated.

 

“Class I” shall mean the
class of directors whose term of office shall expire at the 2021 meeting of the stockholders of the Company.

 

“Class II” shall mean the
class of directors whose term of office shall expire at the 2019 annual meeting of the stockholders of the Company.

 

“Class III” shall mean
the class of directors whose term of office shall expire at the 2020 annual meeting of the stockholders of the Company.

 

“Common Stock” shall have
the meaning set forth in the Recitals hereto.

 

“Company” shall mean NCI
Building Systems, Inc., a Delaware corporation, and its successors and assigns.

 

“Company Default Event”
shall mean, at any time prior to a CD&R Investor Rights Termination Event, either of the following events:

 

(i)        the
failure of any CD&R Investor Nominee to be elected to the Board within 45 calendar days following any annual or special meeting
of stockholders of the Company at which such individual stood for election but was nevertheless not elected, provided that
there shall be no Company Default Event as a result of this clause (i) if such individual (or an alternate designated by the CD&R
Investor Group) is elected or appointed to the Board (regardless of whether such individual accepts such appointment or complies
with any obligations relating to such individual’s appointment or service) prior to the expiration of such 45-day period;
or

 

(ii)        the
removal of a CD&R Investor Director from the Board without cause other than by action, or at the request or direction, directly
or indirectly, of the CD&R Investor Group.

 

“Competitor” shall mean
any Person that manufactures, engineers, markets, sells or provides, within North America, (i) metal building systems or components
(including, without limitation, primary and secondary framing systems, roofing panels and/or systems, end or side wall panels,
sectional or roll-up doors, insulated metal panels, windows, or other metal components of a building structure), (ii) coated or
painted steel or metal coils, (iii) coil coating or coil painting services, (iv) vinyl or aluminum windows, (v) vinyl or aluminum
siding, fencing and stone products or (vi) the engineering, marketing, selling and providing of the items referred to in clauses
(i) – (v) in the aggregate either (x) is the primary business of such Person or (y) such Person and its Affiliates generated
revenue from such items for the twelve (12) months comprising its most recently completed four fiscal quarters equal to or greater
than 50% of the aggregate revenue of the Company during such period.

 

    	 	- 6 -	 

     

    

 

“Continuing Directors”
shall mean (i) the directors who constitute the Initial Board, (ii) any person becoming a director subsequent to the date of this
Agreement whose election or nomination for election was approved by the affirmative majority vote of the directors who are Continuing
Directors at the time of such election or nomination (either by a specific vote or by approval of the proxy statement of the relevant
party in which such Person is named as a nominee for director, without written objection to such nomination), (iii) all Unaffiliated
Shareholder Directors and (iv) all CD&R Investor Directors, even if the individuals serving as CD&R Investor Directors
should change.

 

“Controlled Affiliate”
shall mean any Affiliate of the specified Person that is, directly or indirectly, controlled (as defined in the definition of “Affiliate”)
by the specified Person.

 

“Covered Securities” shall
mean any equity of the Company (including Common Stock, preferred stock or restricted stock), or any Equity Equivalents, in each
case, other than Excluded Securities.

 

“Designated Securities”
shall have the meaning set forth in Section 5.2(a).

 

“Directed Offer” shall
mean any so-called “registered direct” sale, block trade or other similar offering or Transfer that is not widely distributed.

 

“Disclosed Party” shall
have the meaning set for in Section 8.1(b).

 

“Disclosing Party” shall
have the meaning set for in Section 8.1(b).

 

“Equity Equivalents” shall
mean any securities, options or debt of the Company that are convertible or exchangeable into equity of the Company (or securities,
options or debt convertible into or exercisable therefor), or that include an equity component (such as an “equity”
kicker) (including any hybrid security).

 

“Exchange Act” shall mean
the Securities Exchange Act of 1934, or any successor federal statute, and the rules and regulations promulgated thereunder, all
as amended, and as the same may be in effect from time to time.

 

“Excluded Securities” shall
mean any securities that are (i) issued by the Company pursuant to any employment contract, employee or benefit plan, stock purchase
plan, stock ownership plan, stock option or equity compensation plan or other similar plan, to or for the benefit of any employees
(including new employees), officers or directors of the Company or any of its Subsidiaries, (ii) issued by the Company in
connection with business combinations, mergers, or acquisitions of assets or securities of another Person, or (iii) issued upon
the conversion, exchange or exercise of any security or right or purchase obligation that either (x) is outstanding as of the date
hereof in accordance with its terms as such terms exist as of the date hereof or (y) becomes outstanding after the date hereof
if the security being converted, exchanged or exercised, was issued after the date hereof and was a Covered Security at the time
of its issuance.

 

    	 	- 7 -	 

     

    

 

“Fund VIII CD&R Investors”
shall mean CD&R Fund VIII and CD&R FF Fund VIII.

 

“Golden Gate Investor”
shall have the meaning set forth in the preamble.

 

“Golden Gate Investor Group”
shall have the meaning set forth in the preamble.

 

“Golden Gate Investor Portfolio Company”
shall mean any portfolio company of Golden Gate Parent or a Golden Gate Investor with respect to which neither Golden Gate Parent,
nor such Golden Gate Investor nor any of their respective Affiliates (excluding such portfolio company and its Controlled Affiliates)
exercises control over investment decisions with respect to the Company’s securities, or encouraged, influenced or facilitated
any such decision or action by such portfolio company with respect to the Company’s securities; provided, that (a)
neither Golden Gate Parent, a Golden Gate Investor or any of its Affiliates (excluding such portfolio company and its Controlled
Affiliates) shall provide or have provided to such portfolio company or any of its Controlled Affiliates any non-public information
concerning the Company or any Subsidiary of the Company and (b) such portfolio company is not acting at the request or direction
of or in coordination with any of Golden Gate Parent, Golden Gate Investor or any of their respective Controlled Affiliates (excluding
such portfolio company and its Controlled Affiliates) with respect to the Company’s securities.

 

“Golden Gate Investor Group Voting
Interest” shall mean, as of any date, with respect to the Golden Gate Investor Group, the ratio, expressed as a percentage,
of (i) the aggregate number of votes that may be cast by holders of Common Stock Beneficially Owned by the Golden Gate Investor
Group at the relevant time, divided by (ii) the Aggregate Voting Power at the relevant time.

 

“Golden Gate Investor Rights Termination
Event” shall be deemed to have occurred if, at any time following the Closing Date, the Golden Gate Investor Group Voting
Interest is less than 7.5%.

 

“Golden Gate Parent” shall
mean any entity that is or performs the functions of, directly or indirectly, the managing member or general partner of any Golden
Gate Investor or is the investment manager with respect to such entity and all such entities collectively.

 

“Golden Gate Parent Controlled Affiliate”
shall mean Golden Gate Parent and any individuals that are partners, managing members or have similar titles with respect thereto,
together with the Controlled Affiliates of any of them or any Golden Gate Investor or any entity with respect to which Golden Gate
is the investment manager.

 

“Golden Gate Standstill Termination
Event” shall be deemed to have occurred on the last day of the first continuous six-month period during which the Golden
Gate Investor Group Voting Interest is less than 10.0%.

 

“Group” shall mean any
“group” as such term is used in Section 13(d)(3) of the Exchange Act.

 

    	 	- 8 -	 

     

    

 

“Hedge” shall mean to enter
into any agreement, arrangement, transaction or series of transactions, including any swap or any repurchase or similar so-called
“stock borrowing” agreement or arrangement, that hedges, mitigates or transfers, in whole or in part, directly or indirectly,
the economic consequence of ownership of Common Stock or any other security of the Company, or which provides, directly or indirectly,
the opportunity to profit or share in any profit derived from any decrease in the price or value of Common Stock or any other security
of the Company, in each case regardless of whether any such agreement, arrangement transaction or series of transactions is to
be settled by delivery of securities, in cash or otherwise.

 

“Hedging Limitation Period”
shall mean, with respect to each CD&R Investor and each Golden Gate Investor, the period from the date hereof until the later
of (i) the 30-month anniversary of the Closing Date and (ii) the occurrence of a CD&R Standstill Termination Event, in the
case of any CD&R Investor, and a Golden Gate Standstill Termination Event, in the case of each Golden Gate Investor.

 

“Indenture” shall mean
that certain Indenture, dated as of April 12, 2018, among the Company (as successor by merger to Ply Gem Midco, Inc.), as issuer,
the subsidiary guarantors from time to time party thereto and Wilmington Trust, National Association, as trustee, as the same may
be amended, supplemented, waived or otherwise modified from time to time.

 

“Independent Director”
shall mean a director who (i) is not an Affiliate of the CD&R Investors, the Golden Gate Investor Group or of the Company and
(ii) would qualify as an “Independent Director” pursuant to the listing standards of the NYSE, or, if the securities
of the Company are not quoted or listed for trading on the NYSE, pursuant to the rules of the stock exchange on which the securities
of the Company are then quoted or listed for trading, with respect to (x) the CD&R Investors, the Golden Gate Investor Group
and their respective Affiliates (as if such Persons were listed on the NYSE or such other stock exchange) and (y) the Company (including
that such individual has, and in the period starting three (3) years prior to the date of determination and ending on the date
of determination has had, no material relationship with either the CD&R Investors, the Golden Gate Investor Group or their
respective Affiliates or the Company (excluding such individual’s service, if any, as a director on the board of (1) not
more than one of the CD&R Investors’ or the Golden Gate Investors’ portfolio companies, or (2) the Company)).

 

“Independent Non-CD&R Investor
Directors” shall mean the Independent Directors on the Board who are not CD&R Investor Directors.

 

“Initial Board” shall mean
the directors who are members of the Board effective as of the Closing.

 

“Investors” shall have
the meaning set forth in the preamble.

 

“IRS” shall have
the meaning set forth in Section 9.1(b).

 

“IRS Form” shall have the
meaning set forth in Section 9.1(b).

 

    	 	- 9 -	 

     

    

 

“Law” shall mean applicable
federal, state, local or foreign law, statute, ordinance, rule, regulation, judgment, order, injunction, decree or agency requirement
of any United States or foreign governmental or regulatory agency, commission, court, body, entity, authority or self-regulatory
organization.

 

“Merger Agreement” shall
have the meaning set forth in the Recitals hereto.

 

“Non-Qualified Business Combination”
shall mean a Business Combination that is not a Qualified Business Combination.

 

“NYSE” shall mean the New
York Stock Exchange.

 

“Other CD&R Investor Director”
shall mean any Other CD&R Investor Nominee who is elected or appointed to the Board, from time to time, and the directors on
the Initial Board who are designated as such on Schedule 3.1(a).

 

“Other CD&R Investor Nominee”
shall mean an individual who (i) is designated by the CD&R Investor Group in writing to the Company for election to the Board,
or is designated as a replacement director for appointment to the Board, pursuant to Section 3.1(c)(i) or Section 3.1(c)(ii), and
(ii) is neither a CD&R Nominee nor a CD&R Investor Independent Nominee.

 

“Parent Controlled Affiliate”
shall mean any CD&R Parent Controlled Affiliate, in the case of any CD&R Investor and the CD&R Investor Group, and
any Golden Gate Parent Controlled Affiliate, in the case of each Golden Gate Investor and the Golden Gate Investor Group.

 

“Permitted Increase” shall
mean (i) an acquisition of Qualified Debt or (ii) an acquisition of securities of the Company or its Subsidiaries as the result
of (A) the exercise of subscription rights pursuant to ARTICLE V, (B) any repurchase or redemption of securities by the Company
or (C) any other right of the CD&R Investor Group or transaction contemplated by this Agreement or the other Transaction Documents.

 

“Permitted Third Party Transferee”
shall have the meaning set forth in Section 4.1(b).

 

“Person” shall mean a legal
person, including any individual, corporation, company, partnership, joint venture, association, joint-stock company, trust, limited
liability company or unincorporated association, or any other entity or organization, including a government or any agency or political
subdivision thereof, or any other entity of whatever nature.

 

“Private Placement” shall
have the meaning set forth in Section 5.2(b).

 

“Proceeds” shall mean,
for purposes of Section 6.1(a)(iii), the cash proceeds to the Company from the issuance or sale of any capital stock, other than
options and warrants, plus, with respect to options and warrants, the aggregate exercise price and/or conversion price that would
be received by the Company if all of such options were to be exercised or converted in full.

 

    	 	- 10 -	 

     

    

 

“Proprietary Information”
shall have the meaning set forth in Section 8.1(a).

 

“Qualified Business Combination”
shall mean a Business Combination immediately following which: (i) the individuals and entities that were the Beneficial Owners
of Common Stock outstanding immediately prior to such Business Combination Beneficially Own, directly or indirectly, more than
50% of the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors
(or equivalent) of the entity resulting from such Business Combination (including, without limitation, a corporation that, as a
result of such transaction, owns the Company or all or substantially all of the Company’s assets either directly or indirectly
through one or more Subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination
of the voting power of Common Stock, and (ii) no Person or Group (excluding the CD&R Investor Group and their Affiliates) either
(x) Beneficially Owns, directly or indirectly, more of the combined voting power of the then-outstanding voting securities entitled
to vote generally in the election of directors (or equivalent) of such entity than the CD&R Investor Group and their Affiliates
so Beneficially Own, and, solely in the case of the application of this definition for purposes of clause (iii) of Section 4.1(a),
the CD&R Investor Group and their Affiliates shall Beneficially Own, directly or indirectly, more than 17.5% of the combined
voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or equivalent)
of such entity, or (y) Beneficially Owns, directly or indirectly, 25% or more of the combined voting power of the then-outstanding
voting securities entitled to vote generally in the election of directors (or equivalent) of such entity.

 

“Qualified Debt” means
(i) any term loans advanced pursuant to, or outstanding under, the Cash Flow Credit Agreement and (ii) any notes issued pursuant
to, or outstanding under, the Indenture.

 

“Qualified Debt Holder”
shall mean, at any time, any CD&R Investor and any CD&R Parent Controlled Affiliate, in each case that is a holder of record
of Qualified Debt at such time.

 

“Qualified Offering” shall
mean any public or nonpublic offering of Covered Securities.

 

“Registrable Securities”
shall have the meaning set forth in the Registration Rights Agreement.

 

“Registration Rights Agreement”
shall mean the Registration Rights Agreement, dated as of the date hereof, executed and delivered among the Company, the CD&R
Investors and the Golden Gate Investor Group concurrently with the execution and delivery of this Agreement.

 

“Securities Act” shall
mean the U.S. Securities Act of 1933, and any similar or successor federal statute, and the rules and regulations promulgated thereunder,
all as amended, and as the same may be in effect from time to time.

 

    	 	- 11 -	 

     

    

 

“Series B Preferred Stock”
shall have the meaning set forth in the Recitals hereto.

 

“Standstill Termination Event”
shall mean a CD&R Standstill Termination Event, in the case of any CD&R Investor and the CD&R Investor Group, and a
Golden Gate Standstill Termination Event, in the case of any Golden Gate Investor and the Golden Gate Investor Group.

 

“Tax Returns” shall mean
any return, report or similar filing (including the attached schedules thereto) filed or required to be filed with respect to Taxes
(and any amendments thereto), including any information return, claim for refund or declaration of estimated Taxes.

 

“Taxes” shall mean any
and all domestic or foreign, federal, state, local or other taxes of any kind (together with any and all interest, penalties, additions
to tax and additional amounts imposed with respect thereto) imposed by any Governmental Entity (such Governmental Entity, a “Tax
Authority”), including taxes on or with respect to income, franchises, windfall or other profits, gross receipts, property,
sales, use, capital stock, payroll, employment, unemployment, social security, workers’ compensation or net worth, and taxes
in the nature of excise, withholding, ad valorem or value added, and including any liability in respect of any items described
above as a transferee or successor, or pursuant to Section 1.1502-6 of the Treasury Regulations (or any similar provision
of state, local or foreign Law), or as an indemnitor, guarantor, surety or in a similar capacity under any contract, arrangement,
agreement, understanding or commitment (whether oral or written).

 

“Transfer” shall have the
meaning set forth in Section 4.1(a).

 

“Transferee” shall have
the meaning set forth in Section 4.1(a).

 

“Transfer Exception” shall
have the meaning set forth in Section 4.1(a).

 

“Transfer Limitation Period”
shall mean any time during the period from the Closing Date to (a) the date that is 18 months after the Closing Date, with respect
to CD&R Pisces, and (b) the later of (i) the date that is 90 days after the Closing Date and (ii) January 31, 2018, with respect
to the Fund VIII CD&R Investors and the Golden Gate Investor Group; provided that the Transfer Limitation Period shall
terminate upon the occurrence of (x) a Company Default Event or (y) a Change of Control Event.

 

“Unaffiliated Shareholder”
shall mean any Company stockholder who is not Affiliated with the Investors.

 

“Unaffiliated Shareholder Directors”
shall mean any member of the Board who is not (i) a CD&R Investor Director or (ii) the Chief Executive Officer of the Company.

 

“Underlying Sale” shall
have the meaning set forth in Section 5.5.

 

“Voting Agreement Termination Event”
shall mean either of the following: (i) with respect to any CD&R Investor or any Golden Gate Investor, a Change of Control
Event, or (ii) with respect to any CD&R Investor, a CD&R Standstill Termination Event, and with respect to any Golden Gate
Investor, a Golden Gate Standstill Termination Event.

 

    	 	- 12 -	 

     

    

 

“Voting Interest” shall
mean, as of any date, with respect to a specified Person(s), the ratio, expressed as a percentage, of (i) the aggregate number
of votes that may be cast by holders of Common Stock Beneficially Owned by such Person(s) at the relevant time divided by (ii)
the Aggregate Voting Power at the relevant time.

 

ARTICLE
II

REPRESENTATIONS AND WARRANTIES

 

Section 2.1Representations and Warranties
of the Company. The Company represents and warrants to the Investors as of the date hereof as follows:

 

(a)       The
Company has been duly incorporated and is validly existing as a corporation in good standing under the Laws of the State of Delaware,
and has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated
hereby.

 

(b)       The
execution, delivery and performance of this Agreement by the Company and the consummation of the transactions contemplated hereby
have been duly authorized by all necessary corporate action on the part of the Company.

 

(c)       This
Agreement has been duly authorized, validly executed and delivered by the Company, and assuming due authorization, execution and
delivery of this Agreement by the CD&R Investors and the Golden Gate Investors, constitutes a valid and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except to the extent that the enforcement thereof
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting the enforcement of creditors’
rights generally and general equitable principles, regardless of whether such enforceability is considered in a proceeding at Law
or in equity (“Bankruptcy Exceptions”).

 

Section 2.2Representations and Warranties
of the CD&R Investor Group. Each of the CD&R Investors represents and warrants to the Company as of the date hereof
as follows:

 

(a)       Each
of the CD&R Investors has been duly organized and is validly existing and in good standing under the Laws of the jurisdiction
of its organization, and has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions
contemplated hereby.

 

(b)       The
execution, delivery and performance of this Agreement by each of the CD&R Investors and the consummation of the transactions
contemplated hereby have been duly authorized by all necessary action on the part of such CD&R Investor.

 

(c)       This
Agreement has been duly authorized, validly executed and delivered by each of the CD&R Investors, and assuming due authorization,
execution and delivery of this Agreement by the Company, constitutes a valid and binding obligation of each of the CD&R Investors,
enforceable against each of the CD&R Investors in accordance with its terms, except to the extent that the enforcement thereof
may be limited by the Bankruptcy Exceptions.

 

Section 2.3Representations and Warranties
of the Golden Gate Investor Group. Each Golden Gate Investor represents and warrants to the Company as of the date hereof as
follows:

 

(a)       Each
of the Golden Gate Investors has been duly organized and is validly existing and in good standing under the Laws of the jurisdiction
of its organization, and has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions
contemplated hereby.

 

    	 	- 13 -	 

     

    

 

(b)       The
execution, delivery and performance of this Agreement by each of the Golden Gate Investors and the consummation of the transactions
contemplated hereby have been duly authorized by all necessary action on the part of such Golden Gate Investor.

 

(c)       This
Agreement has been duly authorized, validly executed and delivered by each of the Golden Gate Investors, and assuming due authorization,
execution and delivery of this Agreement by the Company, constitutes a valid and binding obligation of each of the Golden Gate
Investors, enforceable against the Golden Gate Investor in accordance with its terms, except to the extent that the enforcement
thereof may be limited by the Bankruptcy Exceptions.

 

ARTICLE
III

GOVERNANCE MATTERS; VOTING; STANDSTILL PROVISIONS

 

Section 3.1Board of Directors.

 

(a)       Initial
Board. The Initial Board shall consist of the individuals set forth on Schedule 3.1(a), each serving, effective as of the Closing,
in the class of the Board set forth beside their name on such schedule.

 

(b)       Chief
Executive Officer. At all times at which the position of Chief Executive Officer of the Company is filled, one of the members
of the Board shall be the Chief Executive Officer of the Company.

 

(c)       CD&R
Investor Directors.

 

    	 	- 14 -	 

     

    

 

(i)       CD&R
Investor Director Nomination, Appointment and Election. From and after the Closing until the CD&R Investor Rights Termination
Event (the “CD&R Investor Rights Period”), the CD&R Investor Group shall be entitled to nominate for
election, fill vacancies and appoint replacements for a number of CD&R Investor Directors up to the CD&R Investor Director
Number. At each annual meeting or special meeting of stockholders during the CD&R Investor Rights Period at which any directors
of the Company are to be elected, the Company shall take all corporate and other actions necessary to cause the applicable CD&R
Investor Nominees to be nominated for election as directors on the Board and will use its reasonable best efforts to solicit proxies
in favor of the election of such CD&R Investor Nominees to be elected at such meeting, in each case for a term expiring at
the annual meeting of stockholders at which the term for directors in such CD&R Investor Nominee’s class of directors
shall expire and until such CD&R Investor Nominee’s successor shall have been duly elected and qualified or at such earlier
time (if any) as such CD&R Investor Nominee may resign, retire, die or be removed as a director of the Company. During the
CD&R Investor Rights Period, (1) if the number of CD&R Investor Directors exceeds the CD&R Investor Director Number,
unless otherwise requested by the Company by action of the Independent Non-CD&R Investor Directors, the CD&R Investor Group
shall promptly (and in any event, if so requested, prior to the time at which the Board next takes any action, whether at a meeting
or by written consent) cause one or more of the CD&R Directors or the Other CD&R Investor Directors to resign such that,
following the resignations of such individuals, the number of CD&R Investor Directors no longer exceeds the CD&R Investor
Director Number at such time; provided, however, that if the number of CD&R Investor Directors exceeds the CD&R
Investor Director Number solely due to a vacancy in the number of Independent Non-CD&R Investor Directors, which vacancy the
Unaffiliated Shareholder Directors intend to fill, in lieu of causing the resignation of one or more CD&R Directors or the
Other CD&R Investor Directors, the CD&R Investor Group may cause one or more CD&R Directors or Other CD&R Investor
Directors to recuse himself, herself or themselves from voting or granting consent with respect to any Board action taken until
such vacancy is filled such that, during the period of such vacancy, the aggregate number of votes cast or consents granted by
the CD&R Investor Directors with respect to any such matter does not exceed the CD&R Investor Director Number, and (2)
if the limitations and requirements imposed by Law, regulation or the rules of a stock exchange on which the securities of the
Company are quoted or listed for trading require a change to the number of CD&R Investor Directors that are not CD&R Investor
Independent Directors, following consultation with the Board, the CD&R Investors shall promptly cause one or more of the CD&R
Directors or the Other CD&R Investor Directors to resign and, if, following such resignations, the number of CD&R Investor
Directors falls below the CD&R Investor Director Number, CD&R Investor Independent Nominees shall be designated and appointed
to the Board in accordance with the terms of Section 3.1(c)(ii) so that, following such appointments, the number of CD&R Investor
Directors equals the CD&R Investor Director Number. Notwithstanding anything to the contrary in this Agreement, at all times
during the CD&R Investor Rights Period, (x) the CD&R Investor Director Number shall not be less than one (1), and (y) at
any time during which the CD&R Investor Director Number is five (5) or more, at least one (1) CD&R Investor Director must
be an Independent Director.

 

(ii)       CD&R
Investor Director Replacements and Vacancies. The CD&R Directors who are members of the Nominating and Corporate Governance
Committee (or if none serve thereon, the remaining CD&R Directors or, if no CD&R Directors remain in office, the CD&R
Investor Group) shall have the right to designate (x) any replacement for a CD&R Investor Director upon the death, resignation,
retirement or removal from office of such director and (y) fill any other vacancy or vacancies of the Board to the extent that
the number of CD&R Investor Directors is less than the CD&R Investor Director Number, and the Company and the Board will
use its reasonable best efforts to take all corporate and other actions necessary to cause the CD&R Investor Nominees designated
pursuant to this sentence to be appointed to the Board.

 

    	 	- 15 -	 

     

    

 

(iii)       Board
Observer. Upon the occurrence of any Company Default Event, the CD&R Investor Group shall have the right to designate an
individual (a “Board Observer”) to attend (without voting rights) each meeting of the Board or any committee
thereof (and to receive from the Company, subject to the execution and delivery of a customary confidentiality agreement, copies
of all notices, information and other material it provides to the Board and committees thereof) until such time as such Company
Default Event is cured. The Company agrees that each Board Observer shall be entitled to reimbursement for its participation and
related expenses as if such Board Observer were a director of the Company.

 

(iv)       CD&R
Investor Director Title and Position. Until such time as the CD&R Investor Voting Interest is less than 20%, the CD&R
Investor Group shall have the right, in its sole discretion, either (A) to cause one of the CD&R Investor Directors serving
on the Executive Committee of the Board to have the title of Chairman of the Executive Committee or (B) to cause one of the CD&R
Investor Directors serving on the Board to have the title “Lead Director.”

 

(v)       D&O
Insurance. During the CD&R Investor Rights Period, the Company (A) agrees that the CD&R Investor Directors shall be
entitled to the same rights, privileges and compensation as the other members of the Board in their capacity as such, including
with respect to insurance coverage and reimbursement for Board participation and related expenses and (B) shall purchase and maintain,
at its own expense, directors and officers liability insurance, from reputable carriers, in an aggregate amount customary for a
business of the type and size of the Company, whose shares are listed on a public exchange, on behalf of and covering the individuals
who at any time on or after the Closing are or become directors of the Company, against expenses, liabilities or losses asserted
against or incurred by such individual in such capacity or arising out of such individual’s status as such, subject to customary
exclusions; provided that in no event shall such amount of coverage be less than the amount of coverage provided under the
Company’s directors and officers liability insurance as of the date hereof.

 

(vi)       CD&R
Investor Obligations with Respect to CD&R Investor Nominees. With respect to each annual meeting of stockholders of the
Company occurring during the CD&R Investor Rights Period, any of the CD&R Investors, on behalf of the CD&R Investor
Group shall notify the Company of the individuals it nominates as the applicable CD&R Investor Nominees in writing and shall
provide, or cause such individuals to provide, to the Company, such information about such individuals and the nomination to the
Company, at such times as the Company may reasonably request in order to ensure compliance with applicable securities Laws and
the rules of a stock exchange on which the securities of the Company are quoted or listed for trading, and to enable the Board
to make determinations with respect to the qualifications of the individuals to be CD&R Investor Nominees. Notwithstanding
the foregoing, a nomination shall be deemed to have been made if a CD&R Director, who is a member of the Nominating and Corporate
Governance Committee, shall affirm at a meeting of the Nominating and Corporate Governance Committee that, in such individual’s
capacity as a representative of the CD&R Investor Group, he or she is making the nomination on behalf of the CD&R Investor
Group. The Company shall not be obligated to take actions to elect or appoint to the Board any CD&R Investor Nominee until
such CD&R Investor Nominee has been identified and has provided the information required by the preceding sentence to the Company.

 

    	 	- 16 -	 

     

    

 

(vii)       Termination
of CD&R Investor Rights. All obligations of the Company pursuant to this Section 3.1(c) shall terminate, and the CD&R
Investor Group shall, upon request by the Company by action of the Independent Non-CD&R Investor Directors, cause each CD&R
Director and Other CD&R Investor Director to resign from the Board, promptly upon the occurrence of the CD&R Investor Rights
Termination Event (and in any event prior to the time at which the Board next takes any action, whether at a meeting or by written
consent). As a condition to the nomination, election or appointment of any CD&R Nominee or Other CD&R Investor Nominee,
each such individual shall agree in writing with the Company to offer to resign from the Board and/or any committees thereof promptly
upon the occurrence of a CD&R Investor Rights Termination Event (and in any event prior to the time at which the Board next
takes any action, whether at a meeting or by written consent) or as otherwise required pursuant to this Section 3.1(c) or Section
3.1(e).

 

(d)       Unaffiliated
Shareholder Directors.

 

(i)       The
number of directors constituting the full Board of directors initially shall be 12, and thereafter shall be set from time to time
by the Board by affirmative vote of a majority of the directors then in office, provided that, prior to the CD&R Investor Rights
Termination Event, such majority must include a majority of the CD&R Investor Directors and a majority of the Independent Non-CD&R
Investor Directors. Until the occurrence of the CD&R Investor Rights Termination Event, the Board at all times shall be comprised
of (1) the Chief Executive Officer, (2) such number of CD&R Investor Directors as the CD&R Investor Group determines, not
to exceed the CD&R Investor Director Number, (3) Independent Non-CD&R Investor Directors, and (4) up to one (1) additional
Unaffiliated Shareholder Director who upon election would not be an Independent Non-CD&R Investor Director, provided that if
the election or appointment of such Person would have the effect of reducing the CD&R Investor Director Number, no such Person
shall be nominated or appointed without the approval of the CD&R Investor Directors.

 

(ii)       The
Nominating and Corporate Governance Committee shall, so long as Independent Non-CD&R Investor Directors constitute a majority
of the Nominating and Corporate Governance Committee, or, if they do not, then the Independent Non-CD&R Investor Directors,
acting by majority vote shall, (x) select the individual or individuals to be nominated for election as an Unaffiliated Shareholder
Directors at each meeting of stockholders at which Unaffiliated Shareholder Directors are to be elected, (y) (1) select any replacement
for an Unaffiliated Shareholder Director upon the death, resignation, retirement or removal from office of any such director and
(2) fill any other vacancy or vacancies of the Board other than a vacancy to be filled by a CD&R Investor Nominee, and the
Company and the Board will use their reasonable best efforts to take all corporate and other actions necessary to cause the individual
or individuals designated pursuant to this sentence to be appointed to the Board.

 

    	 	- 17 -	 

     

    

 

(iii)       At
any annual meeting or special meeting of stockholders of the Company at which any Unaffiliated Shareholder Directors are to be
elected, the Company shall take all corporate and other actions necessary to nominate for election as directors on the Board each
of the Unaffiliated Shareholder Director(s) whose term expires at such meeting (or other individual(s) selected by the Nominating
and Corporate Governance Committee or the Independent Non-CD&R Investor Directors (as provided in Section 3.1(d)(ii)).

 

(iv)       During
the CD&R Investor Rights Period, each CD&R Investor shall cause each share of Common Stock Beneficially Owned by it to
be present in person or represented by proxy at all meetings of stockholders of the Company at which an individual nominated to
serve as an Unaffiliated Shareholder Director pursuant to this Section 3.1(d) is to be elected, so that all such shares shall be
counted as present for determining the presence of a quorum at such meetings and to vote such shares, at such meetings or at any
adjournments or postponements thereof or by written consent, as appropriate, proportionately with the Unaffiliated Shareholders
with respect to the nominees who would be Unaffiliated Shareholder Directors upon their election.

 

(v)       Notwithstanding
anything to the contrary in this Agreement or in the Certificate of Incorporation, until the CD&R Investor Rights Termination
Event, an Unaffiliated Shareholder Director may not be removed except by the affirmative vote (including by written consent) of
an Unaffiliated Shareholder or Unaffiliated Shareholders holding 80% of all of the Unaffiliated Shareholders’ Voting Interest.
During the CD&R Investor Rights Period, each CD&R Investor shall cause each share of Common Stock Beneficially Owned
by it to be present in person or represented by proxy at all meetings of stockholders of the Company at which the removal of an
Unaffiliated Shareholder Director is to be voted on, so that all such shares shall be counted as present for determining the presence
of a quorum at such meetings and (A) in the event that an Unaffiliated Shareholder or Unaffiliated Shareholders holding a
majority of all of the Unaffiliated Shareholders’ Voting Interest vote (including by written consent) in
favor of the removal of an Unaffiliated Shareholder Director, each CD&R Investor shall vote each share of Common Stock Beneficially
Owned by it for the removal of such Unaffiliated Shareholder Director and (B) otherwise, each CD&R Investor shall vote
(including by written consent) each share of Common Stock Beneficially Owned by it against the removal of such Unaffiliated Shareholder
Director.

 

(e)       Committees.

 

    	 	- 18 -	 

     

    

 

(i)       General.
Subject to applicable Law, regulation or the rules of a stock exchange on which the securities of the Company are quoted or listed
for trading and Section 3.1(e)(ii), for so long as the CD&R Investor Voting Interest is equal to or greater than 20%, the CD&R
Investor Group shall also be entitled to representation proportionate to the CD&R Investor Voting Interest (rounded to the
nearest whole number) on all committees of the Board, provided that, notwithstanding the foregoing, (i) the CD&R Investor
Group shall be entitled to have a minimum of one (1) CD&R Investor Director serving on each committee of the Board (except
that (A) where a CD&R Investor Director is in a conflict position, such CD&R Investor Director may not serve on a special
committee of the Board, and (B) where any CD&R Investor is in a conflict position, none of the CD&R Directors or Other
CD&R Investor Directors may serve on the relevant special committee of the Board) and (ii) each committee shall have at least
one (1) Independent Non-CD&R Investor Director, and (iii) in no event, shall the CD&R Investor Directors compose a majority
of any committee. If as a result of the application of the preceding sentence no CD&R Investor Director may serve on a certain
committee, the CD&R Investor Group shall be entitled to appoint a Board Observer to such committee (who shall not have voting
rights), so long as any such Board Observer meets any applicable independence rules of the stock exchange on which the securities
of the Company are quoted or listed for trading. The CD&R Directors who are members of the Nominating and Corporate Governance
Committee (or if none serve thereon, the remaining CD&R Directors or, if no CD&R Directors remain in office, the CD&R
Investor Group) shall have the right to designate the CD&R Investor Director(s) to serve as members of a committee, and the
Unaffiliated Shareholder Directors shall have the right to designate the Unaffiliated Shareholder Director to serve as a member
of a committee, in each case in accordance with this Section 3.1(e)(i).

 

(ii)       Affiliate
Transactions Committee. During the CD&R Investor Rights Period, the Board shall establish and maintain an Affiliate Transactions
Committee, which shall be comprised of (x) the Unaffiliated Shareholder Directors then in office and (y) one CD&R Investor
Independent Director, if a CD&R Investor Independent Director is then serving on the Board, and otherwise, the Chief Executive
Officer of the Company serving as a director on the Board. Such Affiliate Transactions Committee shall review, consider and approve
any Affiliate Transactions, and no such Affiliate Transactions shall be effected without the prior approval of a majority of the
directors on the Affiliate Transactions Committee; provided, that, for so long as the provisions in Article TENTH of the
Certificate of Incorporation, as in effect on the date hereof, are still in effect, an Affiliate Transaction that is subject to
Article TENTH of the Certificate of Incorporation may be effected in accordance with Section 1(i) thereof if all of the conditions
specified in paragraph A of such Section 1 are met, in lieu of the review, consideration or approval of the Affiliate Transactions
Committee pursuant to this Section 3.1(e)(ii).

 

(iii)       Termination
of CD&R Investor Rights. All obligations of the Company pursuant to Section 3.1(e)(i) and 3.1(e)(ii) shall terminate, and
the CD&R Investor Group shall, unless otherwise requested by the Company by action of the Independent Non-CD&R Investor
Directors, cause each CD&R Director and Other CD&R Investor Director to resign from each committee of the Board, (x) in
the case of Section 3.1(e)(i), if CD&R Investor Voting Interest is less than 20%, and (y) in the case of Section 3.1(e)(ii),
upon the occurrence of the CD&R Investor Rights Termination Event.

 

    	 	- 19 -	 

     

    

 

(f)       Listing.

 

(i)       During
the CD&R Investor Rights Period, the Company shall keep the CD&R Investor Group informed, on a current basis, of any events,
discussions, notices or changes with respect to any Tax (other than ordinary course communications which reasonably could not be
expected to be material to the Company), criminal or regulatory investigation or action involving the Company or any of its Subsidiaries
(other than routine audits or ordinary course communications which reasonably could not be expected to be material to the Company)
that have been brought to the attention of the Board, and reasonably shall cooperate with the CD&R Investor Group, their members
or their respective Affiliates in an effort to avoid or mitigate any cost or regulatory consequences to them that might arise from
such investigation or action (including by reviewing written submissions in advance, attending meetings with authorities and coordinating,
and providing assistance in meeting with regulators).

 

(ii)       From
and after the Closing, the Company shall use its reasonable best efforts to maintain the listing of shares of Common Stock after
issuance on each securities exchange on which Common Stock is then listed or quoted, and the CD&R Investor Group shall support
and not oppose such efforts.

 

Section 3.2Voting. At any time
following the Closing, at any and all meetings of stockholders of the Company occurring prior to a Voting Agreement Termination
Event, each CD&R Investor and Golden Gate Investor shall cause each share of Common Stock Beneficially Owned by it and its
Parent Controlled Affiliate to be present in person or represented by proxy at all meetings of stockholders of the Company, so
that all such shares shall be counted as present for determining the presence of a quorum at such meetings and to vote, at such
meetings or at any adjournments or postponements thereof or by written consent, (a) in favor of all director nominees nominated
by the Board for election by the stockholders in accordance with the terms of this Agreement and the By-laws, (b) as recommended
by the Board, on any and all (i) proposals relating to or concerning compensation or equity incentives for directors, officers
or employees of the Company adopted in the ordinary course of business consistent with past practice, (ii) proposals by stockholders
of the Company (including under Rule 14a-8 of the Exchange Act), and (iii) proposals the subject matter of which is a CD&R
Investor Consent Action, provided that, in respect of clauses (i) and (iii) only, that the Board’s recommendation is consistent
with the CD&R Investor Group’s exercise of their consent rights provided in Article VI hereof in connection with such
CD&R Investor Consent Action and the submission of such proposal occurred in a reasonably timely manner and such proposal has
not failed to receive the requisite number of affirmative votes for the adoption of such proposal since the CD&R Investor Group’s
exercise of their consent right in connection therewith, and (c) not in favor of any transaction constituting, or that would result
in, a Change of Control (provided that, for purposes of this Section 3.2, the term “Business Combination” shall be
deemed to be substituted for the term “Non-Qualified Business Combination” in clause (ii) of the definition of such
term) that has not been approved by a majority of the Independent Non-CD&R Investor Directors, if the per-share consideration
to be received by any CD&R Investor or Golden Gate Investor in connection with such transaction is not equal to, and in the
same form as, the per-share consideration to be received by the Unaffiliated Shareholders.

 

    	 	- 20 -	 

     

    

 

Section 3.3Standstill and Other Restrictions.
(1) During the period from the Closing until a Standstill Termination Event, each Golden Gate Investor and each CD&R Investor,
and each of their respective Parent Controlled Affiliates, shall not, directly or indirectly: (i) other than by a Permitted Increase,
in any way acquire, offer or propose to acquire, or agree to acquire, in any manner (including by means of merger, consolidation,
reorganization, recapitalization or otherwise), Beneficial Ownership of any securities of the Company or its Subsidiaries (including
convertible securities) if immediately following such acquisition or agreement the CD&R Investor Group together with its Parent
Controlled Affiliates, or the Golden Gate Investor Group together with its Parent Controlled Affiliates, as the case may be, would
Beneficially Own in the aggregate more than the Voting Interest or economic interest of the Company that such CD&R Investor
Group or the Golden Gate Investor Group, as the case may be, held at Closing, treating securities convertible into or exercisable
for voting securities, economic interests or Common Stock that are Beneficially Owned by such CD&R Investor or Golden Gate
Investor or their respective Parent Controlled Affiliates as fully converted into or exercised for the underlying voting securities,
economic interests or Common Stock without regard to the exercisability, vesting or similar provisions and restrictions thereof),
provided, however, that in the case of the CD&R Investor Group, if CD&R Investor Voting Interest or economic interest
of the Company at any time falls below 45.0%, then for purposes of clause (i) of this Section 3.3(a), the aggregate cap applicable
to the CD&R Investor Group and CD&R Parent Controlled Affiliate will be 45.0% in lieu of the CD&R Investor Voting Interest
or economic interest as of the Closing, (ii) make any statement or proposal to the Board or any of the Company’s representatives
or stockholders regarding, or make any public announcement, proposal or offer with respect to, any Business Combination, merger,
exchange or tender offer, recapitalization or similar transaction or recapitalization of debt, provided, however,
that any CD&R Investor or Golden Gate Investor may privately communicate such proposal to the Board or the Chief Executive
Officer of the Company as long as such communication would not, and would not reasonably be expected to, trigger public disclosure
obligations for any Person, (iii) deposit any voting securities of the Company into a voting trust, enter into voting agreements,
pooling arrangements or other similar arrangements or contracts, or grant any proxies with respect to any voting securities of
the Company, except to such Investor’s respective Affiliates, (iv) participate in any Group other than with respect to the
its Affiliates, (v) enter into any transaction involving the Company not approved or recommended by the Board, (vi) act with another
party to seek to control or influence the Company (it being understood that, subject to their fiduciary duties to the Company,
no actions taken by the CD&R Directors in their respective roles as members of the Board shall be deemed to violate this clause
(vi)) or (vii) publicly seek, or announce their support for another party to seek, any amendment, waiver or release of, or contest
the validity of, any of the restrictions contained in this Section 3.3(a) (including this clause (vii)) by the Company. The restrictions
of this Section 3.3(a) shall terminate upon the occurrence of a Change of Control Event. Notwithstanding the foregoing, if a majority
of the Independent Non-CD&R Investor Directors consent in writing prior thereto, any Qualified Debt Holder may exchange Qualified
Debt for equity securities of the Company on terms and conditions agreed to in writing by the Company (by approval of a majority
of the Independent Non-CD&R Investor Directors) and such Qualified Debt Holder.

 

    	 	- 21 -	 

     

    

 

(b)       During
the Hedging Limitation Period, the CD&R Investors and their Parent Controlled Affiliates shall not, directly or indirectly,
without the prior written consent of a majority of the Independent Non-CD&R Investor Directors: (i) in any way acquire, offer
or propose to acquire or agree to acquire, directly or indirectly, in any manner, Beneficial Ownership of any indebtedness or debt
securities of the Company other than Qualified Debt or (ii) seek, directly or indirectly, any amendment, waiver or release of,
or to contest the validity of, any of the restrictions contained in this Section 3.3(b) (including this clause (ii)) by the Company.

 

(c)       Notwithstanding
anything to the contrary contained in this Agreement, the restrictions of this Section 3.3 shall not apply upon the occurrence
of any Company Default Event; provided that the restrictions of this Section 3.3 shall apply from and after the date that
such Company Default Event is cured or remedied until the date upon which such restriction terminates in accordance with this Section
3.3.

 

ARTICLE
IV

TRANSFER AND HEDGING RESTRICTIONS

 

Section 4.1Transfer Restrictions.
(2) Prior to the expiration of its applicable Transfer Limitation Period, without the approval of a majority of the Independent
Non-CD&R Investor Directors, any CD&R Investor or Golden Gate Investor shall not transfer, sell, pledge, assign or otherwise
dispose of (including by merger or otherwise by operation of Law) (“Transfer”) any Registrable Securities, other
than, (i) to its Parent Controlled Affiliate, in each case, that agrees to be bound by the provisions of this Agreement as if it
were such CD&R Investor or Golden Gate Investor (a “Transferee”), as applicable, hereunder (for the avoidance
of doubt, any such Transferee shall be included in the term “CD&R Investor” or “Golden Gate Investor,”
as applicable), (ii) to the Company or (iii) in a Business Combination approved, or recommended to the stockholders of the Company,
by the Board (so long as such approval and recommendation has not been revoked prior to the Transfer) in which the per-share consideration
received by such CD&R Investor or Golden Gate Investor, divided by the number of shares of Common Stock Beneficially Owned
by such CD&R Investor or Golden Gate Investor (treating any securities convertible into or exercisable for Common Stock (or
securities convertible into or exercisable therefor) as fully converted into or exercised for the underlying Common Stock) is equal
to, and in the same form as, the per-share consideration received by all holders of Common Stock (other than holders that are the
counterparty to such transaction or an Affiliate of such counterparty); provided, in the event all holders of Common Stock
have the opportunity to elect the form of consideration to be received in such Business Combination, such CD&R Investor or
Golden Gate Investor shall have the opportunity to make such election with respect to the consideration described in this clause
(iii) on the same basis as all holders of Common Stock (each of the exceptions described in clauses (i) through (iii), a “Transfer
Exception”). In the event any Person who is a Transferee pursuant to clause (i) of the preceding sentence ceases to be
a Parent Controlled Affiliate, then any prior Transfer to such Person pursuant to clause (i) shall become null and void and ownership
and title to any such Registrable Securities so Transferred shall revert to the relevant CD&R Investor or Golden Gate Investor,
as applicable. Each CD&R Investor or Golden Gate Investor shall immediately notify the Company if it engages in any of the
transactions referred to in this Section 4.1. Each CD&R Investor or Golden Gate Investor shall give the Company notice of any
proposed Transfer not less than five (5) Business Days prior to any Transfer (or the entering into of any agreement relating to
a Transfer).

 

    	 	- 22 -	 

     

    

 

(b)       Following
its applicable Transfer Limitation Period, each CD&R Investor or Golden Gate Investor shall not Transfer any of the Registrable
Securities, except as follows: (i) the Registrable Securities may be Transferred by each CD&R Investor or each Golden Gate
Investor (A) in a privately negotiated transaction (including any Directed Offer if negotiated between such CD&R Investor or
such Golden Gate Investor (or its agents or representatives) and any Transferee (or its agents or representatives)) to a Person
or Group that represents that it, and that such Transferee reasonably believes, (1) is not a Competitor, (2) is not and will not
be, after giving effect to the Transfer, a 10% Holder or an Affiliate of any 10% Holder and (3) is not proposing to effect a Change
of Control of the Company without the prior written consent of a majority of the Independent Non-CD&R Investor Directors (such
Person, a “Permitted Third Party Transferee”); provided that the Transferring Investor shall have provided
the Company five (5) Business Days’ notice in writing prior to any such Transfer, (B) in public market trades (which shall
include any Directed Offer that is not of the type referred to in clause (A) above); provided that the Transferring Investor
shall have no reason to believe that any Transferee is not a Permitted Third Party Transferee and the Transferring Investor shall
have instructed the Transferring Investor’s underwriters or brokers, if any, of the requirements of a Permitted Third Party
Transferee, and (C) in a traditional underwritten public offering (excluding any Directed Offer) in accordance with the Registration
Rights Agreement and (ii) the Registrable Securities may be Transferred pursuant to a Transfer Exception. The restrictions of this
Section 4.1(b) shall terminate upon the occurrence of a Change of Control Event

 

(c)       The
Investors’ rights under this Agreement will not be Transferable to any Transferee of any Registrable Securities, other than,
in the case of a CD&R Investor, a Transferee that is a CD&R Parent Controlled Affiliate, and, in the case of each Golden
Gate Investor, a Transferee that is an Affiliate of such Golden Gate Investor (and that, in each case, has entered into an agreement
with the Company as set forth in Section 4.1(a)). In the event any Person who is a Transferee pursuant to the preceding sentence
ceases to be a CD&R Parent Controlled Affiliate or an Affiliate of the relevant Golden Gate Investor, as applicable, then any
prior Transfer to such Person shall become null and void and ownership and title to any such Registrable Securities, and the rights
under this Agreement, so Transferred shall revert to the relevant CD&R Investor or Golden Gate Investor, as applicable.

 

(d)       Any
certificates for Registrable Securities shall bear a legend or legends (and appropriate comparable notations or other arrangements
will be made with respect to any uncertificated shares) substantially to the following effect:

 

THIS INSTRUMENT WAS ORIGINALLY
ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, (THE “SECURITIES
ACT”) AND THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR SECURITIES LAWS
OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A REGISTRATION STATEMENT RELATING THERETO IS
IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN EXEMPTION THEREFROM UNDER SUCH ACT OR SUCH LAWS.

 

    	 	- 23 -	 

     

    

 

In addition, for so long as the restrictions of this ARTICLE
IV remain in effect, such legend or notations will include language substantially to the following effect:

 

THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A STOCKHOLDERS AGREEMENT, DATED [●], 2018, AMONG
THE ISSUER OF SUCH SECURITIES (THE “COMPANY”) AND THE OTHER PARTY OR PARTIES THERETO. A COPY OF THE PROVISIONS OF SUCH
AGREEMENT SETTING FORTH SUCH RESTRICTIONS ON TRANSFER IS ON FILE WITH THE SECRETARY OF THE COMPANY.

 

The holder of any certificate(s) bearing any such legend (or
any uncertificated shares subject to such notations or arrangements) shall be entitled to receive from the Company new certificates
for a like number of Registrable Securities not bearing such legend (or the elimination or termination of such notations or arrangements)
promptly upon the request of such holder at any time when (i) the restrictions on Transfer pursuant to this Agreement are no longer
applicable, and (ii) an opinion of counsel to such holder has been delivered to the Company, which opinion is reasonably satisfactory
to the Company, to the effect that the restriction referenced in such legend (or such notations or arrangements) is no longer required
in order to ensure compliance with the Securities Act and applicable state Laws.

 

Section 4.2Hedging Restrictions.
Each CD&R Investor and each Golden Gate Investor agrees that, during the Hedging Limitation Period, it and its Parent Controlled
Affiliate shall not Hedge their respective direct or indirect exposure to Common Stock or any other security , except in transactions
involving an index-based portfolio of securities that includes Common Stock (provided that the value of such Common Stock
in such portfolio is not more than 5.0% of the total value of the portfolio of securities). For the avoidance of doubt, following
the Hedging Limitation Period, nothing in this Section 4.2 shall prohibit any CD&R Investor or Golden Gate Investor, or their
respective Parent Controlled Affiliates from Hedging their respective direct or indirect exposure to Common Stock or any other
security , including any transactions involving an index-based portfolio of securities that includes Common Stock (regardless of
the value of such Common Stock in such portfolio relative to the total value of the portfolio of securities) or involving the purchase
or sale of derivative securities or any short sale of Common Stock.

 

ARTICLE
V

SUBSCRIPTION RIGHTS

 

Section 5.1Subscription Rights.
From and after the Closing, if the Company offers to sell Covered Securities in a Qualified Offering (which may only be effected
in compliance with Section 6.1), each CD&R Investor and each Golden Gate Investor shall be afforded the opportunity to acquire
from the Company, for the same price and on the same terms as such Covered Securities are offered to others, in the aggregate up
to the amount of Covered Securities required to enable such CD&R Investor and Golden Gate Investor to maintain (a) with respect
to offers to sell Covered Securities consisting of Common Stock or Equity Equivalents convertible or exchangeable for Common Stock
(or convertible into or exercisable therefor), its then-current Voting Interest and (b) with respect to offers to sell Covered
Securities consisting of non-voting equity of the Company or Equity Equivalents convertible or exchangeable for non-voting equity
(or convertible into or exercisable therefor), its then-current percentage economic interest.

 

    	 	- 24 -	 

     

    

 

Section 5.2Notice. (3) In the event
the Company intends to make a Qualified Offering of Covered Securities that is an underwritten public offering or a private offering
made to Qualified Institutional Buyers (as such term is defined in Rule 144A under the Securities Act) for resale pursuant to Rule
144A under the Securities Act, no later than five (5) Business Days after the initial filing of a registration statement with respect
to such underwritten offering or the commencement of such Rule 144A offering, the Company shall give each CD&R Investor and
each Golden Gate Investor written notice of its intention (including, in the case of a registered public offering and to the extent
possible, a copy of the prospectus included in the registration statement filed in respect of such offering), describing, to the
extent then known, the anticipated amount of securities, price (or range of prices), timing and other material terms upon which
the Company proposes to offer the same. Each CD&R Investor and each Golden Gate Investor shall have five (5) Business Days
from the date and time of receipt of any such notice to notify the Company in writing that it intends to exercise such subscription
rights and as to the amount of Covered Securities such Investor desires to purchase, up to the maximum amount calculated pursuant
to Section 5.1 (the “Designated Securities”); provided that, notwithstanding anything to the contrary
in this ARTICLE V but subject to Section 3.3 and Section 4.1, to the extent a CD&R Investor elects not to exercise its subscription
rights for the maximum amount calculated pursuant to Section 5.1, (i) any other CD&R Investor may elect to purchase all or
a portion of the Covered Securities elected not to be purchased by the relevant CD&R Investor, and (ii) any CD&R Parent
Controlled Affiliate may elect to purchase all or a portion of the Covered Securities elected not to be purchased by the relevant
CD&R Investor, in the case of each such CD&R Parent Controlled Affiliate, that agrees to be bound by the provisions of
this Agreement as if it were a CD&R Investor hereunder (for the avoidance of doubt, any such Person shall be included in the
term “CD&R Investor”), in the case of each of the preceding clauses (i) and (ii), by giving the notice contemplated
by this sentence with respect to such Covered Securities, and such Covered Securities shall be deemed to be “Designated Securities”
with respect to the CD&R Investor giving such notice. Such notice shall constitute a non-binding indication of interest of
such CD&R Investor to purchase the Designated Securities so specified at the price and other terms set forth in the Company’s
notice to it. The failure of any CD&R Investor or Golden Gate Investor to respond during such five-Business Day period shall
constitute a waiver of subscription rights under this ARTICLE V only with respect to the offering described in the applicable notice
and a notice purporting to exercise subscription rights for more than the maximum amount contemplated by Section 5.1 shall be deemed
to be an election to acquire the maximum amount. To the extent the Company shall give any CD&R Investor and Golden Gate Investor
notice of any such offer prior to the public announcement thereof, each CD&R Investor and each Golden Gate Investor shall agree
to confidentiality and restriction on trading terms reasonably acceptable to the Company.

 

    	 	- 25 -	 

     

    

 

(b)       If
the Company proposes to make a Qualified Offering of Covered Securities that is not an underwritten public offering or Rule 144A
offering (a “Private Placement”), the Company shall (i) give each CD&R Investor and each Golden Gate Investor
written notice of its intention, describing, to the extent then known, the anticipated amount of securities, price and other material
terms upon which the Company proposes to offer the same and (ii) promptly provide each CD&R Investor and each Golden Gate Investor
with an updated notice reflecting any changes to such anticipated amount of securities, price or other material terms. Each CD&R
Investor and each Golden Gate Investor shall have ten (10) Business Days from the date of receipt of the last notice required by
the immediately preceding sentence to notify the Company in writing that it intends to exercise such subscription rights and as
to the amount of Designated Securities such CD&R Investor or Golden Gate Investor desires to purchase, up to the maximum amount
calculated pursuant to Section 5.1; provided that, notwithstanding anything to the contrary in this ARTICLE V but subject
to Section 3.3, to the extent a CD&R Investor elects not to exercise its subscription rights for the maximum amount calculated
pursuant to Section 5.1, (i) any other CD&R Investor may elect to purchase all or a portion of the Covered Securities elected
not to be purchased by the relevant CD&R Investor, and (ii) any CD&R Parent Controlled Affiliate may elect to purchase
all or a portion of the Covered Securities elected not to be purchased by the relevant CD&R Investor, in the case of each such
CD&R Parent Controlled Affiliate, that agrees to be bound by the provisions of this Agreement as if it were a CD&R Investor
hereunder (for the avoidance of doubt, any such Person shall be included in the term “CD&R Investor”), in the case
of each of the preceding clauses (i) and (ii), by giving the notice contemplated by this sentence with respect to such Covered
Securities, and such Covered Securities shall be deemed to be “Designated Securities” with respect to the CD&R
Investor giving such notice. Such notice shall constitute a non-binding indication of interest of such CD&R Investor or Golden
Gate Investor to purchase the amount of Designated Securities so specified at the price and upon other terms set forth in the Company’s
notice to it; provided that the closing of the Private Placement with respect to which such rights has been exercised takes
place within fifteen (15) calendar days after giving notice of such exercise by such CD&R Investor or Golden Gate Investor.
The failure of any CD&R Investor or the Golden Gate Investor to respond during the ten-Business Day period referred to in the
second preceding sentence shall constitute a waiver of the subscription rights under this ARTICLE V only with respect to the offering
described in the applicable notice and a notice purporting to exercise subscription rights for more than the maximum amount contemplated
by Section 5.1 shall be deemed to be an election to acquire the maximum amount. To the extent the Company shall give any CD&R
Investor and Golden Gate Investor notice of any such offer prior to the public announcement thereof, each CD&R Investor and
each Golden Gate Investor shall agree to confidentiality and restriction on trading terms reasonably acceptable to the Company.

 

    	 	- 26 -	 

     

    

 

Section 5.3Purchase Mechanism.
(4) If a CD&R Investor or Golden Gate Investor exercises its subscription rights as provided in Section 5.2(a), the Company
shall offer such CD&R Investor or Golden Gate Investor, if such underwritten public offering or Rule 144A offering is consummated,
the Designated Securities (as adjusted to reflect the actual size of such offering when priced) on the same material terms as the
Covered Securities are offered to the underwriters or initial purchasers and shall provide written notice of such price to such
CD&R Investor or Golden Gate Investor as soon as practicable prior to such consummation. Contemporaneously with the execution
of any underwriting agreement or purchase agreement entered into between the Company and the underwriters or initial purchasers
of such underwritten public offering or Rule 144A offering, such CD&R Investor or Golden Gate Investor shall, if it continues
to wish to exercise its subscription rights with respect to such offering, enter into an instrument in form and substance reasonably
satisfactory to the Company acknowledging its binding obligation to purchase the Designated Securities to be acquired by it and
containing representations, warranties and agreements of such CD&R Investor or Golden Gate Investor that are customary in private
placement transactions and, in any event, no less favorable to such CD&R Investor or Golden Gate Investor than any underwriting
or purchase agreement entered into by the Company in connection with such offering, and the failure to enter into such an instrument
at or prior to such time shall constitute a waiver of the subscription rights in respect of such offering. Any offers and sales
pursuant to this ARTICLE V in the context of a registered public offering shall be also conditioned on reasonably acceptable representations
and warranties of such relevant CD&R Investor or Golden Gate Investor regarding its status as the type of offeree to whom a
private sale can be made concurrently with a registered offering in compliance with applicable securities Laws.

 

(b)       If
any CD&R Investor or any Golden Gate Investor exercises its subscription rights as provided in Section 5.2(b), the closing
of the purchase of the Covered Securities with respect to which such right has been exercised shall be conditioned on the consummation
of the sale of securities pursuant to the Private Placement with respect to which such subscription right has been exercised and
shall take place as soon as practicable after the closing of the Private Placement; provided that such time period shall
be extended for a maximum of 95 days in order to comply with applicable Laws and regulations; provided, further,
that the actual amount of Covered Securities to be sold to such CD&R Investor or Golden Gate Investor pursuant to its exercise
of subscription rights hereunder shall be proportionally reduced if the aggregate amount of Covered Securities sold in the Private
Placement is reduced and, at the option of such CD&R Investor or Golden Gate Investor (to be exercised by delivery of written
notice to the Company within five (5) Business Days of receipt of notice of such increase), shall be increased if such aggregate
amount of Covered Securities sold in the Private Placement is increased. In connection with its purchase of Designated Securities,
such CD&R Investor or Golden Gate Investor shall, if it continues to wish to exercise its subscription rights with respect
to such offering, execute an agreement containing representations and warranties and, if at such time the CD&R Investor Voting
Interest, in the case of any CD&R Investor, or the Golden Gate Investor Group Voting Interest, in the case of any Golden Gate
Investor, is greater than 20%, agreements of such CD&R Investor or Golden Gate Investor that are substantially similar in all
material respects to the agreements executed by other purchasers in such Private Placement. Each of the Company and the CD&R
Investor and each Golden Gate Investor agrees to use its reasonable best efforts to secure any regulatory or stockholder approvals
or other consents, and to comply with any Law or regulation necessary in connection with the offer, sale and purchase of, such
Covered Securities.

 

    	 	- 27 -	 

     

    

 

Section 5.4Failure to Purchase.
In the event that any CD&R Investor or any Golden Gate Investor fails to exercise its subscription rights provided in this
ARTICLE V within the applicable period or, if so exercised, such CD&R Investor or Golden Gate Investor is unable to consummate
such purchase within the time period specified in Section 5.3 above because of its failure to obtain any required regulatory or
stockholder consent or approval or because of the failure to purchase any or all of the Covered Securities contemplated to be purchased
by the election notice, the Company shall thereafter be entitled during the period of sixty (60) days following the conclusion
of the applicable period to sell or enter into an agreement (pursuant to which the sale of the Covered Securities covered thereby
shall be consummated, if at all, within thirty (30) days from the date of said agreement) to sell the Covered Securities not
elected to be purchased pursuant to this ARTICLE V or which such CD&R Investor or Golden Gate Investor is unable to purchase
because of such failure to obtain any such consent or approval or otherwise fails to purchase, at a price and upon terms no more
favorable to the purchasers of such securities in the Private Placement, the underwritten public offering or Rule 144A offering,
as the case may be, than were specified in the Company’s notice to such CD&R Investor or Golden Gate Investor. Notwithstanding
the foregoing, if such sale is subject to the receipt of any regulatory or stockholder approval or consent or the expiration of
any waiting period, the time period during which such sale may be consummated shall be extended until the expiration of five (5) Business
Days after all such approvals or consents have been obtained or waiting periods expired, but in no event shall such time period
exceed ninety (90) days from the date of the applicable agreement with respect to such sale. In the event the Company has not sold
the Covered Securities or entered into an agreement to sell the Covered Securities within said 60-day period (or sold and issued
Covered Securities in accordance with the foregoing within thirty (30) days from the date of said agreement (as such period
may be extended in the manner described above for a period not to exceed ninety (90) days from the date of said agreement),
the Company shall not thereafter offer, issue or sell such Covered Securities without first offering such securities to each CD&R
Investor or Golden Gate Investor in the manner provided above.

 

Section 5.5Certain Qualified Offerings.
In the case of a Qualified Offering of Covered Securities for a consideration in whole or in part other than cash, including securities
acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall be
deemed to be the fair value thereof as determined by a firm of independent public accountants or an independent appraiser, in each
case, of recognized national standing selected by the Board and approved by the Investors; provided, however, that
such fair value as determined in accordance with this Section 5.5 shall not exceed the aggregate market price of the securities
being offered as of the date the Board authorizes the offering of such securities. In the event that the sale of Designated Securities
to any CD&R Investor or any Golden Gate Investor cannot be consummated substantially concurrently with the sale giving rise
to the applicable exercise of subscription rights by such CD&R Investor or Golden Gate Investor under Section 5.1 (the “Underlying
Sale”), consummation of the Underlying Sale shall not be delayed or conditioned upon such sale of Designated Securities
to such CD&R Investor or Golden Gate Investor; provided, in such event, that the Company shall use its best efforts
to consummate the sale of such Designated Securities to such CD&R Investor or Golden Gate Investor as promptly as practicable
following the consummation of the Underlying Sale.

 

    	 	- 28 -	 

     

    

 

Section 5.6Cooperation. The Company
and each CD&R Investor and each Golden Gate Investor shall cooperate in good faith to facilitate the exercise of the CD&R
Investor and Golden Gate Investor subscription rights hereunder, including, without limitation, securing any required approvals
or consents, in a manner that does not jeopardize the timing, marketing, pricing or execution of any offering of the Company’s
securities.

 

Section 5.7Limitation of Rights.
Notwithstanding the above, nothing set forth in this ARTICLE V shall confer upon any CD&R Investor or any Golden Gate Investor
the right to purchase any securities of the Company other than Designated Securities. For the avoidance of doubt, notwithstanding
the above, nothing set forth in this ARTICLE V shall limit any CD&R Investor’s or any Golden Gate Investor’s rights
pursuant to and in accordance with the Registration Rights Agreement, including, without limitation, with respect to notice of
or registration of Registrable Securities in Piggyback Registrations (each as defined in the Registration Rights Agreement).

 

Section 5.8Termination of Subscription
Rights. Anything to the contrary in this ARTICLE V notwithstanding, the CD&R Investors’ and each Golden Gate Investor’s
subscription right to purchase Covered Securities granted by this ARTICLE V shall not be available for any offering that commences
at any time after the occurrence of the CD&R Investor Rights Termination Event or the Golden Gate Investor Rights Termination
Event, respectively.

 

ARTICLE
VI

CONSENT RIGHTS

 

Section 6.1CD&R Investor Consent
Rights.

 

(a)       Until
such time as the CD&R Investor Voting Interest is less than 25%, without the prior consent of the CD&R Investor Group,
the Company shall not, and shall cause each of its Subsidiaries not to, take any of the following actions, commit, resolve or agree
to take any of the following actions or authorize or otherwise facilitate any of the following actions:

 

(i)       in
any fiscal year, acquire, in a single transaction or a series of related transactions, any business organization or division thereof
or assets if in such fiscal year (A) the aggregate consideration paid by the Company for all such acquisitions completed in such
fiscal year would exceed 10% of the Company’s consolidated assets as of the end of the most recently completed fiscal year
or (B) the aggregate contribution to revenue of the businesses, divisions and assets acquired on a pro forma basis for the most
recently completed fiscal year would exceed 10% of the Company’s revenues for the most recently completed fiscal year, excluding,
in all cases, (1) transactions consented to by the CD&R Investor Group, (2) transactions between and among any of the Company
and its direct or indirect wholly owned Subsidiaries and (3) acquisitions of inventory, equipment and real property in the ordinary
course of business;

 

    	 	- 29 -	 

     

    

 

(ii)       in
any fiscal year, sell, transfer or dispose of, in a single transaction or a series of related transactions, any business organization
or division of the Company or any of its assets if in such fiscal year (A) the aggregate consideration received by the Company
for all such sales, transfers or dispositions completed in such fiscal year would exceed 10% of the Company’s consolidated
assets as of the end of the most recently completed fiscal year or (B) the aggregate contribution to revenue of the sold, transferred
or disposed businesses, divisions and assets for the most recently completed fiscal year would exceed 10% of the Company’s
revenues for the most recently completed fiscal year, excluding, in all cases, (1) transactions consented to by the CD&R Investor
Group, (2) transactions between and among any of the Company and its direct or indirect wholly owned Subsidiaries, (3) disposition
of any aircraft owned by the Company and (4) dispositions of inventory, equipment and real property in the ordinary course of business;

 

(iii)       other
than grants in the ordinary course of business consistent with past practice to employees or directors of the Company pursuant
to an existing stock option plan or restricted stock plan, pursuant to another plan or agreement adopted or approved by the Board
in the ordinary course with terms that are consistent with past practice or pursuant to the issuance of shares in respect of any
exercise of options or settlement of any other share-based awards outstanding on the date of this Agreement, or as may be granted
after the date of this Agreement, as permitted by this Agreement, authorize, issue, deliver, sell, pledge, dispose of, grant, award
or encumber any shares (or options, warrants, convertible securities or rights of any kind to acquire or receive any shares) of
capital stock, ownership interests or voting securities if the Proceeds to the Company for all such issuances in the aggregate
exceed $20 million in any given fiscal year;

 

(iv)       redeem,
repurchase or acquire any shares of capital stock or securities convertible into or exercisable for shares of the capital stock,
other than any Registrable Securities or pursuant to the acquisition of shares from a holder of an option, restricted share or
any other share-based award in satisfaction of Tax withholding obligations or in payment of the exercise price, if as a result
of such action the aggregate consideration paid by the Company in respect of all such redemptions, repurchases or acquisitions
since the date of this Agreement would exceed $20 million annually and other than transactions
between and among any of the Company and its direct or indirect wholly owned Subsidiaries;

 

(v)       declare
or pay any extraordinary dividend or distribution (other than dividends or distributions by a direct or indirect wholly owned Subsidiary
of the Company to the Company or a direct or indirect wholly owned Subsidiary of the Company);

 

(vi)       newly
incur or guarantee any indebtedness for borrowed money except for (A) any indebtedness among the Company and its wholly owned Subsidiaries
or among the Company’s wholly owned Subsidiaries, (B) guarantees by the Company and/or any Subsidiary of indebtedness of
the Company or Subsidiaries of the Company, which indebtedness is outstanding as of the date hereof or incurred in compliance with
this Section 6.1(a)(vi), (C) borrowings under the ABL Credit Agreement or the Cash Flow Credit Agreement, in each case without
giving effect to any increase in the commitments thereunder after the date hereof, and (D) additional indebtedness for borrowed
money not to exceed $125 million in aggregate principal amount outstanding at any time;

 

    	 	- 30 -	 

     

    

(vii)       engage
to a material extent in any business in which the Company is not engaged on the Closing Date or any business related, ancillary
or complementary to such business;

 

(viii)       adopt
a plan or agreement of complete or partial liquidation or dissolution (except a liquidation or dissolution
of a direct or indirect wholly owned Subsidiary into the Company or
another wholly owned Subsidiary) or commence a proceeding;

 

(ix)       increase
or decrease the number of directors that would constitute the entire Board at such time assuming all vacancies were filled; or

 

(x)       amend,
alter or repeal any provisions of its Certificate of Incorporation or Bylaws.

 

(b)       Consent
of the CD&R Investor Group to any of the actions specified above may be made in a writing addressed to the Board from any CD&R
Investor, and in addition shall be deemed to have been given if a CD&R Director shall affirm at a meeting of the Board that,
in such individual’s capacity as a representative of the CD&R Investor Group, he or she consents to any such action on
behalf of the CD&R Investor Group.

 

ARTICLE
VII

EFFECTIVENESS AND TERMINATION

 

Section 7.1Termination. This Agreement
will be effective as of the date hereof and will continue in effect thereafter until the earliest of (a) its termination by the
mutual written agreement of the Company (subject to Section 9.3(b)) each CD&R Investor and each Golden Gate Investor, (b) except
as otherwise specifically provided herein with respect to particular Sections of this Agreement, at such time as neither Investor
Beneficially Owns any Registrable Securities and (c) the dissolution, liquidation and winding up of the Company.

 

ARTICLE
VIII

ACCESS, INFORMATION AND CONFIDENTIALITY

 

Section 8.1Confidentiality.

 

    	 	- 31 -	 

     

    

 

(a)       Subject
to Section 8.1(b), each party to this Agreement will hold, will cause its respective directors, officers, partners, employees,
agents, consultants and advisors to hold, and will cause its respective Controlled Affiliates and any other Affiliate to whom it
releases or discloses Proprietary Information and their respective directors, officers, partners employees, agents, consultants
and advisors to hold in strict confidence, all nonpublic records, books, contracts, instruments, computer data and other data and
information, including without limitation, information regarding finances and results, technology, trade secrets, know-how, customers,
vendors, business and/or strategic plans, marketing activities, financial data and other business affairs and any IRS Form and
any documents, supplements or schedules attached thereto or included therein (collectively, “Proprietary Information”)
concerning the other party hereto, its former, current or future representatives or any former, current or future representatives
of such representatives furnished to it by, or on behalf of, such other party pursuant to this Agreement ((x) except to the extent
that such information can be shown to have been (i) previously known by such party on a nonconfidential basis, (ii) in the public
domain through no fault of such party or (iii) later lawfully acquired from other sources not known to or suspected by such party
to be prohibited from disclosing such Proprietary Information by a contractual, legal or fiduciary obligation and (y) solely with
respect to an IRS Form or any document, supplement or schedule attached thereto or included therein, except to the extent such
information is requested or required by the IRS or any other Tax Authority) and neither party hereto shall release or disclose
such Proprietary Information to any other Person, except its auditors, attorneys, financial advisors, other consultants and advisors.

 

(b)       In
the event that any party, any Controlled Affiliates of any party or any of its or their representatives (a “Disclosing
Party”) is requested pursuant to, or required by, applicable Law, regulation or legal process to disclose any Proprietary
Information of the other party (a “Disclosed Party”), then before substantively responding to any such request
or requirement, to the extent permitted by Law, such Disclosing Party will provide, or cause its Controlled Affiliate or its or
their representative to provide, the Disclosed Party with prompt written notice of any such request or requirement so that it may,
at its sole expense, seek a protective order or other appropriate remedy, or both, or waive compliance with the provisions of this
Section 8.1(b) or other appropriate remedy, or if it so directs, the Disclosing Party, will exercise its own reasonable best efforts,
at the Disclosed Party’s expense, to assist it in obtaining a protective order or other appropriate remedy. If, failing the
entry of a protective order or other appropriate remedy or the receipt of a waiver hereunder, disclosure of any Proprietary Information
is, in the opinion of the Disclosing Party’s counsel, required, the Disclosing Party may, without liability hereunder, furnish
only that portion of the Proprietary Information which in the opinion of the Disclosing Party’s counsel is required to be
so furnished pursuant to Law, regulation or legal process.

 

Section 8.2Access and Information.
The Company hereby agrees that it shall ensure that upon reasonable notice, the Company and its Subsidiaries (a) will afford
to each Investor and their respective representatives (including, without limitation, the respective officers and employees of
the Investors, and the respective counsel, accountants and other professionals retained by the Investors) such access during normal
business hours to its books, records (including, without limitation, Tax Returns and appropriate work papers of independent auditors
under normal professional courtesy), properties, personnel, accountants and other professional retained by the Company and to such
other information as such Investor may reasonably request; (b) will furnish the Investors such financial and operating data
and other information with respect to the business and properties of the Company as the Company prepares and compiles for members
of its Board in the ordinary course and as such Investor may from time to time reasonably request; and (c) permit the Investors
to discuss the affairs, finances and accounts of the Company, and to furnish advice with respect thereto, with the principal officers
of the Company within thirty (30) days after the end of each fiscal quarter of the Company. All requests for access and information
shall be coordinated in writing through senior corporate officers of the Company.

 

    	 	- 32 -	 

     

    

 

ARTICLE
IX

MISCELLANEOUS

 

Section 9.1Tax Matters.1

 

(a)       To
the extent permitted by Law, the Company shall treat each CD&R Investor or each Golden Gate Investor that is not a U.S. person
for U.S. federal income tax purposes and any of its non-U.S. Affiliates as a withholding foreign partnership and shall not withhold
on any cash (or other) distributions made or deemed to be made to such CD&R Investor or Golden Gate Investor or to any such
Affiliate so long as such CD&R Investor or Golden Gate Investor or such Affiliate, as the case may be, has provided the Company
with the required documentation.

 

(b)       On
the Closing Date, and from time to time thereafter as any previously delivered form or other document expires or becomes inaccurate
or at any other time as the Company may reasonably request, each CD&R Investor and each Golden Gate Investor shall deliver,
or cause to be delivered, to the Company one or more duly completed Internal Revenue Service (“IRS”) Forms W-8IMY
or other W-8, as applicable (or any subsequent versions thereof or successors thereto), in the case of any CD&R Investor or
any Golden Gate Investor or any of their respective Affiliates that is not a U.S. Person for U.S. federal income tax purposes,
together with any applicable related withholding or other statement or form, and W-9 (or any subsequent versions thereof or successors
thereto), in the case of any Affiliate that is a U.S. person for U.S. federal income tax purposes (each, an “IRS Form”),
in each case confirming, to the extent permitted by law, that the Company is not required to deduct or withhold any amount of U.S.
federal income tax in respect of distributions or deemed distributions by the Company to such CD&R Investor or Golden Gate
Investor (or any Affiliate). Each of the CD&R Investors confirms that it is a withholding foreign partnership (and has entered
into a withholding foreign partnership agreement with the IRS), and each of the CD&R Investors and each Golden Gate Investor
respectively intend for any potential CD&R Investor or Golden Gate Investor, as the case may be, that is not a U.S. Person
for U.S. federal income tax purposes to enter into a withholding foreign partnership agreement with the IRS.

 

Section 9.2Successors and Assigns.
Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto,
in whole or in part (whether by operation of Law or otherwise), without the prior written consent of each of the other parties
(subject to Section 9.3(b)); provided that the Company may assign the rights and obligations under this Agreement to a successor
and the Investors may, pursuant and subject to Section 4.1(a)(i), assign all or a portion of their rights, interests and obligations
under this Agreement, including, without limitation, their rights, interests and obligations under ARTICLE V, without the prior
written consent of the Company, in the case of the CD&R Investors, to any CD&R Parent Controlled Affiliate, and in the
case of any Golden Gate Investor, to any Affiliate of such Golden Gate Investor, but only if the assignee agrees in writing for
the benefit of the Company (with a copy thereof to be furnished to the Company) to be bound by the terms of this Agreement (for
the avoidance of doubt, any such assignee shall be included in the term “CD&R Investor” or “Golden Gate Investor,”
as applicable); provided, further, that no such assignment shall relieve any CD&R Investor or Golden Gate Investor
of its obligations hereunder. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and
be enforceable by the parties and their respective successors and assigns. For purposes of this Agreement, “successor”
for any entity other than a natural person shall mean a successor to such entity as a result of such entity’s merger, consolidation,
sale of substantially all of its assets, or similar transaction. Any attempted assignment in violation of this Section 9.2 shall
be void.

 

 

 

1 Note
to Draft: Relevant tax provisions subject to Golden Gate review.

    	 	- 33 -	 

     

    

 

Section 9.3Amendments; Waiver; Company
Action; CD&R Investor Obligations. (5) Subject to Section 9.3(b): (i) this Agreement may not be modified or amended except
pursuant to an instrument in writing signed by an authorized officer of the Company and each CD&R Investor and Golden Gate
Investor; and (ii) any party may waive in whole or in part any benefit or right provided to it under this Agreement, such waiver
being effective only if contained in a writing executed by the waiving party. No failure by any party to insist upon the strict
performance of any covenant, duty, agreement or condition of this Agreement or to exercise any right or remedy consequent upon
breach thereof shall constitute a waiver of any such breach or of any other covenant, duty, agreement or condition, nor shall any
delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right accruing to
it thereafter.

 

(b)       Solely
with respect to any action by the Company (x) to amend, waive, or enforce or comply with any provision of this Agreement or (y)
to make any determination pursuant to this Agreement in which any CD&R Investor have or may have interests different from the
Company or its stockholders other than the CD&R Investor Group, such action, unless otherwise expressly contemplated by this
Agreement, shall be taken or determination shall be made on behalf of the Company solely by a majority of the Independent Non-CD&R
Investor Directors and the Chief Executive Officer of the Company (though less than a quorum), or, if no Independent Non-CD&R
Investor Directors exist, the Independent Directors and the Chief Executive Officer of the Company (though less than a quorum);
provided, notwithstanding anything to contrary herein, that any action to amend, waive, or enforce or comply with any provision
of this Agreement, or to make any determination pursuant to this Agreement, which provision either (i) relates to the qualifications
for, selection, nomination or election of, or to the powers, rights or privileges of the Unaffiliated Shareholder Directors or
(ii) requires the consent or approval of the Unaffiliated Shareholder Directors, such action shall be taken or determination shall
be made on behalf of the Company solely by the Unaffiliated Shareholder Directors or, if no such directors exist, the Independent
Non-CD&R Investor Directors and the Chief Executive Officer or, if no Independent Non-CD&R Investor Directors exist, the
Independent Directors and the Chief Executive Officer of the Company. No CD&R Investor Director shall have any right to vote
upon, and by a decision of the remaining directors may be excluded from participating in any discussion of, any such action or
determination referenced in the preceding sentence. Each CD&R Investor Director shall, if requested by the remaining directors,
appear at any properly called meeting if their presence is required to establish a quorum.

 

    	 	- 34 -	 

     

    

 

(c)       Any
obligation of the CD&R Investor Group hereunder to take or cause, or to refrain from or prevent, any action shall be joint
and several among the CD&R Investors.

 

Section 9.4Notices. Except as otherwise
provided in this Agreement, all notices, requests, claims, demands, waivers and other communications hereunder shall be in writing
and shall be deemed to have been duly given when delivered by hand or overnight courier service, or when received by facsimile
transmission if promptly confirmed, as follows:

 

If to the Company, to it at:

NCI Building Systems, Inc.

10943 North Sam Houston Parkway
West

Houston, Texas 77064

Attention:
Todd Moore, General Counsel

Email:TrMoore@ncigroup.com

 

with a copy to (which shall not
constitute notice):

Wachtell, Lipton, Rosen & Katz

51 West 52nd Street

New York, New York 10019

Attention:Mark Gordon

Email: MGordon@wlrk.com

 

If to any CD&R Investor,
to them at:

Clayton, Dubilier & Rice Fund VIII, L.P.

CD&R Friends & Family Fund VIII, L.P.

CD&R Pisces Holdings, L.P.

c/o Clayton, Dubilier & Rice, Inc.

375 Park Avenue, 18th Floor

New York, New York 10152

Attention: Theresa Gore

Email: tgore@cdr-inc.com

 

    	 	- 35 -	 

     

    

with a copy to (which shall not
constitute notice):

Debevoise & Plimpton LLP

919 Third Avenue

New York, NY 10022

		Attention:	Paul S. Bird

Christopher Anthony

		Email:	psbird@debevoise.com

canthony@debevoise.com

 

If to the Golden Gate Investor Group,
to it at:

c/o Golden Gate Private Equity, Inc.

One Embarcadero Center, Suite 3900

San Francisco, CA 94111

		Attention:	Rajeev Amara

Stephen Oetgen

		Email:	ramara@goldengatecap.com

soetgen@goldengatecap.com

 

 

with a copy to (which shall not
constitute notice):

Kirkland & Ellis LLP

555 California Street

San Francisco,
California 94104

Attention: Jeremy M. Veit, P.C.

Email: jeremy.veit@kirkland.com

 

or to such other address, facsimile number or telephone as either
party may, from time to time, designate in a written notice given in a like manner.

 

Section 9.5Governing Law. This
Agreement will be governed by and construed in accordance with the Laws of the State of Delaware applicable to contracts made and
to be performed within the State of Delaware, without giving effect to conflicts of law rules that would require or permit the
application of the Laws of another jurisdiction.

 

Section 9.6Specific Performance; Jurisdiction.

 

(a)       The
parties agree that irreparable damage would occur for which money damages would not suffice in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached and that the parties would
not have any adequate remedy at Law. It is accordingly agreed that the non-breaching party or parties shall be entitled to an injunction,
temporary restraining order or other equitable relief exclusively in the Delaware Court of Chancery enjoining any such breach and
enforcing specifically the terms and provisions hereof, or in the event (but only in the event) that such court does not have subject
matter jurisdiction over such action or proceeding, in the United States District Court for the District of Delaware or another
court sitting in the state of Delaware. The foregoing is in addition to any other remedy to which any party is entitled at Law,
in equity or otherwise.

 

    	 	- 36 -	 

     

    

 

(b)       Each
of the parties hereto irrevocably agrees that any legal action or proceeding in connection with or with respect to this Agreement
and the rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect of this Agreement
and the rights and obligations arising hereunder brought by another party hereto or its successors or assigns shall be brought
and determined exclusively in the Delaware Court of Chancery, or in the event (but only in the event) that such court does not
have subject matter jurisdiction over such action or proceeding, in the United States District Court for the District of Delaware
or another court sitting in the state of Delaware. Each of the parties hereto hereby irrevocably submits with regard to any such
action or proceeding for itself and in respect of its property, generally and unconditionally, to the personal jurisdiction of
the aforesaid courts and agrees that it will not bring any action in connection with or relating to this Agreement or any of the
transactions contemplated by this Agreement in any court other than the aforesaid courts. Each of the parties hereto hereby irrevocably
waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in any action or proceeding in connection
with or with respect to this Agreement, (i) any claim that it is not personally subject to the jurisdiction of the above-named
courts for any reason other than the failure to serve in accordance with this Section 9.6, (ii) any claim that it or its property
is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service
of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (iii)
to the fullest extent permitted by applicable Law, any claim that (A) the suit, action or proceeding in such court is brought in
an inconvenient forum, (B) the venue of such suit, action or proceeding is improper or (C) this Agreement, or the subject matter
hereof, may not be enforced in or by such courts.

 

(c)       Each
of the parties hereto irrevocably consents to the service of any summons and complaint and any other process in any other action
in connection with or relating to this Agreement, on behalf of itself or its property, by the personal delivery of copies of such
process to such party or by sending or delivering a copy of the process to the party to be served at the address and in the manner
provided for the giving of notices in Section 9.4. Nothing in this Section 9.6 shall affect the right of any party hereto to serve
legal process in any other manner permitted by Law.

 

Section 9.7Waiver of Jury Trial.
Each party hereby waives, to the fullest extent permitted by applicable law, any right it may have to a trial by jury in respect
of any suit, action or other proceeding arising out of this Agreement or any transaction contemplated hereby. Each party (i) certifies
and acknowledges that no representative, agent or attorney of any other party has represented, expressly or otherwise, that such
other party would not, in the event of litigation, seek to enforce the foregoing waiver, and (ii) acknowledges that it understands
and has considered the implications of this waiver and makes this waiver voluntarily, and that it and the other parties have been
induced to enter into the Agreement by, among other things, the mutual waivers and certifications in this Section 9.7.

 

    	 	- 37 -	 

     

    

 

Section 9.8Headings. The descriptive
headings of the several sections in this Agreement are for convenience only and do not constitute a part of this Agreement and
shall not be deemed to limit or affect in any way the meaning or interpretation of this Agreement.

 

Section 9.9Entire Agreement. This
Agreement, the other Transaction Documents and the schedules and exhibits attached to any such documents constitute the entire
agreement and understanding among the Company and each of the CD&R Investors and Golden Gate Investor with respect to the matters
referred to herein and supersede all prior agreements, understandings or representations, in each case among the parties, with
respect to such matters.

 

Section 9.10Severability. If any
term or provision of this Agreement or any application thereof shall be declared or held invalid, illegal or unenforceable, in
whole or in part, whether generally or in any particular jurisdiction, such provision shall be deemed amended to the extent, but
only to the extent, necessary to cure such invalidity, illegality or unenforceability, and the validity, legality and enforceability
of the remaining provisions, both generally and in every other jurisdiction, shall not in any way be affected or impaired thereby.

 

Section 9.11Counterparts. This
Agreement may be signed in one or more counterparts, each of which shall constitute an original and all of which together shall
constitute one and the same agreement.

 

Section 9.12Interpretation. When
a reference is made in this Agreement to an Article, Section, Exhibit or Schedule, such reference is to an Article or Section of,
or an Exhibit or Schedule to, this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement
are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words
“include,” “includes” and “including” are used in this Agreement, they are deemed to be followed
by the words “without limitation.” For all purposes of this Agreement, except as otherwise expressly provided or unless
the context otherwise requires, (a) the terms defined include the plural as well as the singular, and (b) the words “herein,”
“hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to
any particular Article, Section or other subdivision.

 

Section 9.13No Third Party Beneficiaries.
Nothing in this Agreement, expressed or implied, is intended to confer upon any Person, other than the parties hereto or permitted
assignees of any of the CD&R Investors or any Golden Gate Investor pursuant to Section 4.1(a)(i) and Section 9.2, or their
respective successors, any rights, remedies, obligations or liabilities under or by reason of this Agreement.

 

    	 	- 38 -	 

     

    

 

Section 9.14Investor Portfolio Companies.

 

(a)       Notwithstanding
anything to the contrary in this Agreement, the parties hereby agree that nothing in Section 3.2, Section 3.3 or in Section 4.2
shall apply to any portfolio company of CD&R Parent or any CD&R Investor with respect to which neither CD&R Parent,
such CD&R Investor nor any of their respective Affiliates (excluding such portfolio company and its Controlled Affiliates)
exercises control over the decision of such portfolio company to take any such action that would otherwise be prohibited or required
by Section 3.2, Section 3.3 or Section 4.2, nor assisted, encouraged, influenced or facilitated any such decision or action; provided,
(a) that neither CD&R Parent, any CD&R Investor nor any of their respective Affiliates (excluding such portfolio company
and its Controlled Affiliates) shall provide or have provided to such portfolio company or any of its Controlled Affiliates any
non-public information concerning the Company or any Subsidiary of the Company and (b) such portfolio company is not acting at
the request or direction of or in coordination with any of CD&R Parent, any CD&R Investor or any of their respective Controlled
Affiliates (excluding such portfolio company and its Controlled Affiliates).

 

(b)       Notwithstanding
anything to the contrary in this Agreement, the parties hereby agree that nothing in Section 3.2, Section 3.3 or in Section 4.2
shall apply to any portfolio company of Golden Gate Parent or any Golden Gate Investor with respect to which neither Golden Gate
Parent, such Golden Gate Investor nor any of their respective Affiliates (excluding such portfolio company and its Controlled Affiliates)
exercises control over the decision of such portfolio company to take any such action that would otherwise be prohibited or required
by Section 3.2, Section 3.3 or Section 4.2, nor assisted, encouraged, influenced or facilitated any such decision or action; provided,
(a) that neither Golden Gate Parent, any Golden Gate Investor nor any of their respective Affiliates (excluding such portfolio
company and its Controlled Affiliates) shall provide or have provided to such portfolio company or any of its Controlled Affiliates
any non-public information concerning the Company or any Subsidiary of the Company and (b) such portfolio company is not acting
at the request or direction of or in coordination with any of Golden Gate Parent, a Golden Gate Investor or any of their respective
Controlled Affiliates (excluding such portfolio company and its Controlled Affiliates).

 

Section 9.15Conflicting Agreements.
The Company has not entered into, and, from and after the date hereof, shall not enter into, any agreement, arrangement or understanding
which (i) violates or conflicts with any provision of this Agreement or (ii) impedes or prevents the Company’s ability to
fulfill and comply with its obligations, or any CD&R Investor’s or Golden Gate Investor’s ability to utilize their
rights, set forth herein.

 

    	 	- 39 -	 

     

    

 

Section 9.16Termination of 2009 Stockholders
Agreement. CD&R Fund VIII, CD&R FF Fund VIII and the Company agree that the 2009 Stockholders Agreement is hereby terminated
and of no further force and effect.

 

[remainder
of page intentionally left blank]

 

    	 	- 40 -	 

     

    

 

IN WITNESS WHEREOF, the parties have caused
this Agreement to be duly executed by their respective authorized officers as of the date set forth at the head of this Agreement.

 

	 	NCI Building Systems, Inc.
	 	 	 
	 	By:	 	 
	 	 	Name:
	 	 	Title:

 

 

 

 

 

 

 

[Signature Page to Stockholders Agreement]

     

     

    

 

	 	CLAYTON, DUBILIER & RICE FUND VIII, L.P.
	 	 	 	 
	 	By:	CD&R ASSOCIATES VIII, LTD.,
	 	 	its General Partner
	 	 	 	 
	 	 	 	 
	 	By:	 
	 	 	Name: 	Theresa A. Gore
	 	 	Title: 	Vice President, Treasurer &
	 	 	 	Assistant Secretary
	 	 	 	 
	 	 	 	 
	 	CD&R FRIENDS & FAMILY FUND VIII, L.P
	 	By:	CD&R ASSOCIATES VIII, LTD., 
	 	 	its General Partner
	 	 	 	 
	 	 	 	 
	 	By:	 
	 	 	Name:	Theresa A. Gore
	 	 	Title:	Vice President, Treasurer & 
	 	 	 	Assistant Secretary
	 	 	 	 
	 	 	 	 
	 	CD&R PISCES HOLDINGS, L.P.
	 	 	 	 
	 	By:	CD&R Investment Associates X, Ltd.,
	 	 	its general partner
	 	 	 	 
	 	 	 	 
	 	By:	 
	 	 	Name:	Theresa A. Gore
	 	 	Title:	Vice President, Treasurer & 
	 	 	 	Assistant Secretary

 

 

[Signature Page to Stockholders Agreement]

     

     

    

 

 

	 	ATRIUM INTERMEDIATE HOLDINGS, LLC

 

 

	 	By:	 	 
	 	 	Name:
	 	 	Title:

 

 

 

	 	GGC BP HOLDINGS, LLC

 

 

	 	By:	 	 
	 	 	Name:
	 	 	Title:

 

 

 

	 	AIC FINANCE PARTNERSHIP, L.P.

 

 

	 	By:	 	 
	 	 	Name:
	 	 	Title:

 

 

 

 

[Signature Page to Stockholders Agreement]

     

     

    

 

Schedule 3.1(a)2

 

Initial Board

 

	Name	Class	Director Designation
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

 

2
Note to draft: To complete.Exhibit 10.1

 

 

EMPLOYMENT AGREEMENT

 

EMPLOYMENT AGREEMENT ("Agreement")
dated as of July 1, 2018, between ANIL R. DIWAN, c/o NanoViricides, Inc., 1 Controls Drive, Shelton, CT 06484 ("Employee"),
and NanoViricides, Inc., a corporation with offices at 1 Controls Drive, Shelton, CT 06484("the Company").

 

WHEREAS, the parties hereto desire to enter
into this Agreement in order to set forth the terms pursuant to which the Company will employ the Employee and the Employee will
serve as an employee of the Company.

 

NOW THEREFORE, in consideration of the foregoing
and the mutual agreements set forth herein, the parties hereto, intending to be legally bound, agree as follows:

 

1.       Employment

The Company agrees to employ the Employee, and
the Employee hereby agrees to such employment, subject to the terms and conditions set forth in this Agreement.

 

2.       Term

The term of this Agreement shall commence on
July 1, 2018 and shall continue for three (3) years, i.e. ending June 30, 2021, but subject to the approval of the Board of Directors,
renewable annually thereafter upon approval of the Board of Directors, provided that either party can terminate the employment
at any time, for any reason, upon 30 days’ notice (the “Employment Period”).

 

3.       Position
and Duties

The Employee shall serve as President, and as
Chairman of the Board of Directors, and perform the usual duties of said offices, and shall have responsibility, subject to direction
of the Board of Directors, for participating in the management and direction of the Company's business and operations, and shall
perform such specific other tasks consistent with such position as may from time to time be assigned to him by the Board of Directors.
The Employee shall devote his business time to the performance of his duties hereunder, and shall devote his labor, skill, attention,
and best ability in a manner that will faithfully and diligently further the business and interests of the Company. Upon the commencement
of the Employment Period, the Employee shall fulfill such general management duties and responsibilities as are consistent with
the position of President, at the direction of the Board of Directors. In his capacity as President, the Employee shall endeavor
to (i) assist the Chief Executive Officer in obtaining financing and presenting to investors, (ii) identify and strategize the
requirements for preclinical and clinical development of the Company’s drug candidates; (iii) identify markets for the Company's
products and services; (iv) maintain, expand, and improve the Company's profile in the financial markets; (v) develop strategies
and operational plans for bringing the Company’s products to market; (vi) identify potential business partners for strategic
or marketing alliances; (vii) establish budgets and control costs with regard to the foregoing; (ix) implement the Company's business
strategies; and (x) perform such other tasks as relate to the growth of the Company’s business. The Company shall provide
the necessary support, including financial and administrative support, to the Employee for the execution of his duties.

 

    	 	Page 1 of 11 
	 

     

    

  

Employee shall primarily be based at 1 Controls
Drive, Shelton, Connecticut. The Employee agrees that he will travel to whatever extent it is reasonably necessary in the conduct
of the Company's business; provided, however, that the Employee shall not be required directly or indirectly to relocate without
his consent.

 

4.       Indemnification

A.       Subject
to the provisions of the Company's Articles of Incorporation, as amended from time to time, the Company shall indemnify the Employee
to the fullest extent permitted by the Revised Statutes of the State of Nevada, as amended from time to time, for all amounts (including,
without limitation, judgments, fines, settlement payments, expenses, and attorney's fees) actually and necessarily incurred or
paid by the Employee in connection with any action, suit, investigation, or proceeding arising out of or relating to the performance
by the Employee of services for, or the acting by Employee as an officer or employee of, the Company, or any other person or enterprise
at the Company's request provided that he acted in good faith, for a purpose which he reasonably believed to be in the best interests
of the Company and, in criminal actions or proceedings, in addition, had no reasonable cause to believe that his conduct was unlawful.
The Employee’s expenses incurred in any such action, suit, investigation or proceeding shall be advanced as incurred upon
an undertaking by the Employee to repay such expenses if they are subsequently finally adjudicated and not indemnifiable.

 

B. The Company understands that from time to
time the Employee may need to retain and consult with an external legal firm to assist him with his duties and obligations to the
Company, including but not limited to matters related to the Board of Directors and to the Audit Committee of the Board. The Employee’s
expenses incurred in any such consultations shall be reimbursed by the Company in full upon submission of an appropriate expense
report for approval by the Audit Committee of the Board of Directors.

 

C.       No
indemnification may be made to or on behalf of the Employee if a judgment or final adjudication adverse to the Employee establishes
that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause
of action so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally
entitled.

 

D.       The
Company shall maintain appropriate levels of D&O insurance as well as other insurance for general business and product liability
insurances.

 

5.       Compensation
and Benefits

The total compensation consists of base salary,
fringe benefits, stock awards, incentive awards, and performance bonuses as follows:

 

A.       Base
Salary and Fringe Benefits 

As compensation for the Employee's services
hereunder during the Employment Period, the Company shall pay the Employee a base salary of four hundred thousand ($400,000) dollars
per annum, commencing July 1, 2018, and through the effective period of the contract unless amended by the Compensation Committee. Any base salary payable hereunder shall be paid in regular intervals in accordance with the Company's payroll practices, but
no less frequently than once each month.

 

    	 	Page 2 of 11 
	 

     

    

The Employee shall be entitled to participate
in all fringe benefits the Company provides for its employees generally, and such other benefits as the Company provides generally
for its senior executives. Such fringe benefits may include paid time off (vacation and sick days), right to unpaid FMLA time off,
medical insurance coverage (health, dental and vision), and Employee Retirement Plan, as may exist from time to time. In addition,
the Company shall maintain a Term Life Insurance policy for the Employee, valued at $2 Million, of which $1 Million shall be assigned
to the Company and remaining to the Employee’s Estate.

 

B.       Grant
of Series A Preferred Shares 

As an incentive towards the ultimate success
of the Company, and to provide leadership authority to the Executive, the Company grants 225,000 shares of the Company’s
Series A Preferred Shares to Employee (the “Preferred Stock”) upon execution of this Agreement and the Employee accepts
such grant for itself and its successors and assigns, as follows:

 

(i)    Shareholder
Rights Pertaining to Granted Series A Preferred Shares 

From and after the Grant Date, Employee will
be recorded as a shareholder of the Company with respect to the full amount of the Granted Series A Preferred Shares less any Shares
that are forfeited, transferred back to the Company or otherwise cancelled. Employee shall be entitled, from and after the Grant
Date, to vote the full amount of Granted Shares, whether vested or unvested, less any shares that are forfeited, transferred back
to the Company or otherwise cancelled.

 

(ii)        Transfer
Restrictions; Vesting

 

        (a)
Employee's rights in and to the Shares shall be vested pursuant to the vesting table below and shall be forfeitable unless and
until otherwise vested pursuant to the terms of this Agreement. Provided that the Employee has not experienced a Termination of
Service and remains continuously employed with the Company, the Shares shall become vested following the Grant Date as specified
below with respect to a number of shares of Common Stock (rounded to the nearest whole share) equal to the percentage of the total
number of shares subject to the Award in accordance with the following schedule:

 

	Vesting Date Following Grant Date
 	 	Percent (%) 
 of Shares
                                                                                                          

Vested
 	 
	1st Period: June 30, 2019	 	 	331/3%	
	2nd Period: June 30, 2020	 	 	662/3%	
	3rd Period: June 30, 2021	 	 	100%	

 

               Shares
that have vested and are no longer subject to forfeiture according to the above vesting schedule are referred to herein as "Vested
Shares." Shares that have not vested and remain subject to forfeiture under the preceding schedule are referred to
herein as "Unvested Shares."

 

    	 	Page 3 of 11 
	 

     

    

               (b)
The vesting period and the amount of the Award set forth above shall be adjusted on a prorated basis by the Board of Directors
to reflect the decreased level of employment during any period in which the Employee is on an approved leave of absence or is employed
on a less than full time basis.

 

               (c)
Any sale, transfer, assignment, encumbrance, pledge, hypothecation, conveyance in trust, gift, transfer by bequest, devise or descent,
or other transfer or disposition of any kind, whether voluntary or by operation of law, directly or indirectly, of Unvested Shares
shall be strictly prohibited and void; provided, however, that the Board of Directors, in its sole discretion, may permit the Employee
to assign or transfer an Award, provided that the Award shall be subject to all the terms and condition of this Agreement and any
other terms required by the Board of Directors as a condition to such transfer.

 

(iii).     Forfeiture
upon Termination of Employment; Company Transaction

Upon a Termination of Service for any reason,
including without limitation, termination by the Company for Cause, voluntary resignation by the Employee or the Employee's death,
Disability or Retirement, the Unvested Shares shall be forfeited by the Employee and cancelled and surrendered to the Company without
payment of any consideration to the Employee.

 

C.       Intentionally
omitted.

 

D.        Performance
Bonus

The Employee's performance shall be reviewed
by the Compensation Committee no less frequently than annually and the Compensation Committee shall assist and advise the Board
of Directors as to grants of stock options, increase in base salary, or additional incentive awards, based upon performance evaluation
by the Compensation Committee. The Employee shall not vote on matters specifically and solely related to his compensation.

 

E.       Expense
Reimbursement

The Employee is required to obtain unanimous
approval of the Executive Committee for all events that would require expense reimbursement.

 

The Company shall promptly pay the reasonable
and approved expenses incurred by the Employee in the performance of his duties hereunder, including, without limitation, those
incurred in connection with business-related travel, telecommunications, and entertainment, or, if such expenses are paid directly
by the Employee, shall promptly reimburse the Employee for such payment, provided that Employee has properly accounted therefore
in accordance with the Company's written policy of which the Employee has had reasonable prior notice.

 

F.       Portable
or Cellular Telephone

The Company shall reimburse the Employee for
business-related expenses incurred in the use of a portable or cellular telephone.

 

    	 	Page 4 of 11 
	 

     

    

6.       Termination
and Compensation Provisions

Notwithstanding any other provisions of this
Agreement, the Employee's employment may be terminated:

 

A.       For
Cause. By the Company for Cause upon notice to the Employee.

"Cause" shall mean the Employee’s
having engaged in fraud, embezzlement, theft, commission of a felony or, except as may be required by law or upon advice of counsel,
his having been proven to have made an intentional unauthorized disclosure with the knowledge that such disclosure would materially
harm the Company’s interests including, but not limited to, trade secrets or other proprietary information of the Company
or a subsidiary in violation of written policies regarding disclosure of trade secrets and such information, and the Company believes,
that such disclosure has damaged the Company or its subsidiary in a material manner.

 

B.       Death.
In the event of Employee's death during the term of his employment, the Company's obligation to pay further compensation hereunder
shall cease forthwith, except that Employee's legal representative shall be entitled to (a) receive his monthly compensation for
the period up to the last day of the month in which such death shall have occurred and (b) receive on behalf of the Employee's
estate such benefits as to which the Employee may be entitled under then existing benefit policies and programs.

 

C.        Not
for Cause/Severance. By the Company other than for Cause in which event the Company shall pay to the Employee an amount equal to
six (6) months salary as severance compensation (without regard to compensation or benefits the Employee receives from any other
source). The Employee shall be eligible for all benefits during this 6 month period including bonuses, vesting of previously awarded
stock options, health care insurance and other fringe benefits that have been ongoing prior to the written notice(without regard
to compensation or benefits the Employee receives from any other source). The Company may elect to pay such severance compensation
in a lump sum or in equal payments over a period of not more than six (6) months. If the Employee leaves the employ of the Company
voluntarily as a result of a breach of this Agreement by the Company, there having been as of the date of the Company's breach
no breach of this Agreement by the Employee which has not been cured or waived, then the Employee's termination of employment shall
be deemed to have been a termination by the Company other than for Cause. The Employee may treat reduction in rank or responsibilities
as termination without cause.

 

D.        Voluntary
Termination. The Employee may terminate his service to the Company at any time with a written notice of resignation provided at
least thirty (30) days prior to such termination date. No severance pay shall be payable to the Employee upon voluntary termination
of service by the Employee. However, the Board of Directors may, in its own discretion, award the Employee benefits such as partial
vesting rights to unvested stock options, partial continuation of fringe benefits, cash or stock option bonuses, or other benefits,
in recognition of the Employee’s service.

 

E.        Return
of Company Property, Instruments of Business, Documents, Confidential and Proprietary Information.

 

    	 	Page 5 of 11 
	 

     

    

 

Within 90 days of termination of employment
or death, the Employee (or his legal representative in the case of death), must return all Company Property, including computers,
tablets, and other instruments paid for by the Company, all documents and correspondence related to the Company, and all confidential
and proprietary information that may be in possession of the Employee. The Employee may delete articles of personal content unrelated
to the Company, but shall not otherwise delete any information, software, or other files from soft records.

 

F.       
Employee’s Indebtedness to the Company, if any, and Company’s Obligations to the Employee, if any. Notwithstanding
any of the foregoing provisions of this Section 6, if the Employee is indebted to the Company, the severance pay or other compensation
obligations of the Company or other awards due to the Employee, shall be applied first to such indebtedness, in accordance with
the Company’s records; the excess, if any, shall be paid to said Employee and, in any event, the Employee shall remain liable
for any excess of his/her indebtedness to the Company over any amounts owed by the Company. In addition, upon termination of the
Employee's employment, all loans, expense reimbursements and other amounts owed by the Company to the Employee (other than severance
compensation) shall become immediately due and payable within 90 days. All excess indebtedness of the Employee to the Company,
and all other deliverables by the Employee to the Company, must be satisfied by the Employee within 90 days from the termination
date.

 

7.       Nondisclosure
of Proprietary/Confidential Information

The Employee acknowledges that he will have
access to information about the Company and his employment with the Company shall, throughout the Employment Period, bring him
into close contact with many confidential affairs of the Company, its subsidiaries and affiliates, and their respective customers,
including, without limitation, information proprietary to the Company, trade secrets, and other confidential material, which information
is not readily available to the public and all of which is highly confidential and proprietary and was developed at great effort
and expense (such material, "Confidential Information"). Employee further acknowledges that the timelines for drug development
process are extra-ordinarily long, often requiring as many as ten to twenty years from project initiation to product approval.
In recognition of the foregoing, during the Employment Period and for a period of SEVEN(7) years thereafter, regardless of the
reason for any termination of employment (whether voluntary or involuntary and whether for Cause or otherwise), the Employee shall
not, without the written consent of the Board of Directors of the Company, disclose, or use or make available for anyone to use
(except in the course of his employment hereunder and in furtherance of the business of the Company, its subsidiaries, or its affiliates)
any Confidential Information and the Employee shall during the continuance of his employment by the Company use his best efforts
to prevent the unauthorized publication or misuse of any Confidential Information; provided, however, that Confidential Information
shall not include any information (i) known generally to the public (other than as a result of unauthorized disclosure by the Employee)
or (ii) developed by the Employee without violating any of the provisions of this Agreement.

 

The Employee agrees that upon termination of
his employment with the Company for any reason, voluntary or involuntary, with or without Cause, he will immediately return to
the Company all Confidential Information within his possession (or under his control), and shall not at any time thereafter copy
or reproduce the same.

 

    	 	Page 6 of 11 
	 

     

    

 

8.       Restrictive
Covenant

A.       Employee
recognizes and acknowledges that during employment the Employee will have access to, learn, be provided with, and, in some cases,
will prepare and create certain confidential proprietary business information, including, but not limited to, client and customer
information and customer lists, all of which are of substantial value to the Company's business. The Employee agrees that in addition
to any other limitation, for a period of twenty four (24) months after the termination of employment hereunder by him or for any
reason by the Employer, the Employee will not, on his behalf or on behalf of any other person, firm, or corporation, call on any
of the Employer’s, or that of any of its affiliates or subsidiaries, customers, Investors, analysts, Investment bankers,
brokers, or other persons or businesses with which the employer and/ or Its subsidiaries or affiliates had communicated, solicited
Investment, or solicited for any business purposes, for the purpose of soliciting and/or providing to any of these customers any
non-public information relating to the Company's business, nor will the Employee in any way, directly or indirectly, for himself,
or on behalf of any other person, firm, or corporation competing with the Company, solicit, divert, or take away any customers
of the Employer, its affiliates, or its subsidiaries. In the event of an actual or threatened breach by the Employee of the provisions
of this paragraph, the Company shall be entitled to injunctive relief restraining the Employee from the breach or threatened breach.
Nothing herein shall be construed as prohibiting the Company from pursuing any other remedies available to the Company for such
breach or threatened breach, including the recovery of damages from the Employee.

 

B.       During
the course of employment and for a period of two (2) years from the date of termination of this Agreement by him or for Cause,
Employee shall not, directly or indirectly, individually or on behalf of persons not now parties to this agreement, or as a partner,
stockholder, director, officer, principal, agent, employee, or in any other capacity or relationship, engage in any business or
employment, or aid or endeavor to assist any business or legal entity to engage in a business utilizing technology or other products
or businesses that directly compete with the Company's then current customer sales and / or products in development (as of termination).
Employee acknowledges the reasonableness of this restrictive covenant and the reasonableness of the geographic area and duration
that are a part of this covenant.

 

C.       The
Company recognizes that the Employee has had years of experience in the pharmaceutical, drug development, diagnostic and health
care industry, and that concomitant with such experience is a network of personal and business relationships already established
prior to employment with the Company, and nothing in Sections 7, 8 or 9 will limit the business or activities of Employee except
for the restriction on disclosure of proprietary and confidential information set forth in Section 7 and independently developed
by the Company, but limited to the extent that such Information, and contacts have not been disclosed by the Company to third parties.

 

9.       Non-Solicitation
of Former Employees

Employee agrees that during his employment with
Employer and for twenty four(24) months, after termination of employment by him or for cause, the Employee will not, on behalf
of himself or on behalf of any other person, firm, or corporation, solicit for hire, nor for twenty four (24)months after such
termination, hire any of the professional or scientific employees of the Company employed as of such termination.

 

    	 	Page 7 of 11 
	 

     

    

 

10.       Independence
and Severability

Each of the rights enumerated in Sections 7,
8 and 9 (the Restrictive Covenant, Nondisclosure, and No-Solicitation clauses) shall be independent of the others and shall be
in addition to and not in lieu of any other rights and remedies available to the Company at law or in equity. If any of the covenants
contained in Sections 7, 8 or 9, or any part of any of them is hereafter construed or adjudicated to be invalid or unenforceable,
the same shall not affect the remainder of the covenant or covenants or rights or remedies, which shall be given full effect without
regard to the invalid portions. If any of the covenants contained in Sections 7, 8 and 9 is held to be invalid or unenforceable
because of the duration of such provision or the area covered thereby, the parties agree that the court making such determination
shall have the power to reduce the duration and/or area of such provision to the maximum extent permissible under applicable law(s)
and in its reduced form said provision shall then be enforceable.

  

11.       Specific
Remedies

A.       The
Employee acknowledges that the Company shall suffer irreparable injury if he breaches his obligations under Sections 7, 8 and 9.
Accordingly, in the event of such breach, and notwithstanding the provisions of Article 14, Arbitration, the Employee acknowledges
that the Company will be entitled to injunctive relief in any state or federal court of competent jurisdiction within Connecticut.
The Employee further submits to the personal jurisdiction of such courts for the purposes of any such action.

 

B.       Employee
hereby acknowledges that his services are unique and extraordinary, and are not readily replaceable, and hereby expressly agrees
that the Company, in enforcing the covenants contained herein, in addition to any other remedies provided for herein or otherwise
available at law, shall be entitled in any court of equity having jurisdiction to an injunction restraining him in the event of
a breach, actual or threatened, of the agreements and covenants contained in these paragraphs.

 

12.       Employee's
Duty to Mitigate

In the event Employee's employment is actually
or constructively terminated by the Company prior to the end of the Employment Period, whether or not such termination is for Cause,
Employee agrees to exert reasonable efforts to seek alternative employment in the same or substantially similar position as that
held with the Company and at the same or substantially similar remuneration.

 

13.       Cooperation
Following Termination

Provided that he is fairly compensated for his
time and reimbursed for his out-of-pocket expenses, the Employee agrees that, following notice of termination of his employment,
(i) he will cooperate fully with the Company in all matters relating to the completion of his pending work on behalf of the Company
and the orderly transition of such work to such other employees as the Company may designate; and (ii) he will cooperate with the
Company as to any and all claims, controversies, disputes, or complaints over which he has any knowledge or that may relate to
him or his employment relationship with the Company. Such cooperation includes, but is not limited to, providing the Company with
all information known to him related to such claims, controversies, disputes, or complaints and appearing and giving testimony
in any forum.

 

    	 	Page 8 of 11 
	 

     

    

 

14.       Arbitration

To ensure rapid and economical resolution of
any and all disputes directly or indirectly arising out of, or in any way connected or related to the Executive's employment with
the Company or the termination of that employment, the Company and the Executive each agree that any and all such dispute, whether
of law or fact of any nature whatsoever, shall, if dispute cannot be resolved within thirty days despite good faith negotiation,
be resolved by final and binding arbitration by The American Arbitration Association - Commercial Division ("AAA") in
New Haven, CT. The Employee agrees to submit to binding arbitration for the resolution of any employment related controversy, dispute
or claim ("Employment Related Claim"). The term "Employment Related Claim" means any dispute, claim, or controversy
against the Company, including claims related to salary, bonuses, stock, options, vacation pay, fringe benefits, expense reimbursement,
severance benefits, wrongful discharge, defamation, fraud, and breach of good faith and fair dealing, whether arising out of Employee's
employment, the cessation of Employee's employment or any terms or conditions of Employee's employment, or arising out of this
Agreement (including the restrictive covenant hereunder), which could have been brought before an appropriate government administrative
agency or in an appropriate court. Arbitration pursuant to this Agreement shall be the exclusive means for resolution of such claims
and the Company and the Employee understand that by signing this Agreement, they are waiving the right to obtain any legal or equitable
relief from any government agency or court, or to commence any court action or to have a jury trial. Notwithstanding the foregoing,
Employee does not waive his right to file a complaint with the Equal Employment Opportunity Commission pursuant to Title VII, the
ADEA, and/or the OWBPA.

 

The arbitrator's decision shall be final and
binding. The arbitrator shall have the power to award all legal or equitable relief that would have been available in a court of
law, including the costs of arbitration, to the extent such damages are allowed under law.

 

Employee further acknowledges that he has been
advised of his right to consult legal counsel with regard to this Agreement.

 

The arbitration shall be governed by the laws
of the State of Connecticut.

 

15.       Governing
Law

This Agreement shall be governed by and construed
in accordance with the laws of the State of Connecticut (without giving effect to conflicts of law). Only the state and federal
courts of Connecticut shall have jurisdiction over any controversies regarding this Agreement; any action may be brought only in
those courts in Connecticut and the United States District Court for the District of Connecticut having jurisdiction of the subject
matter. Any process in any such action may be served upon either party by delivering it or mailing it, certified mail, directed
to the addresses listed in Section 19.

 

    	 	Page 9 of 11 
	 

     

    

 

16.       Integration

This Agreement constitutes the entire understanding
between the parties hereto relating to the subject matter hereof, superseding all negotiations, prior discussions, preliminary
agreements, and agreements related to the subject matter hereof made prior to the date hereof.

 

17.       Modifications
and Amendments

This Agreement may be modified or amended only
by an instrument in writing executed by the parties hereto and approved in writing by a majority of the Board of Directors. Such
modification or amendment will not become effective until such approval has been given.

 

18.       Severability

If any of the terms or conditions of this Agreement
shall be declared void or unenforceable by any court or administrative body of competent jurisdiction, such term or condition shall
be deemed severable from the remainder of this Agreement, and the other terms and conditions of this Agreement shall continue to
be valid and enforceable.

 

19.       Notice

For the purpose of this Agreement, notices and
all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given as of the
date delivered if delivered in person or by telecopy or if mailed, by express courier, postage prepaid, addressed as follows:

 

	If to Employee:	c/o Nanoviricides, Inc. 
	 	1 Controls Drive
	 	Shelton, CT 06484
	 	 
	If to the Company:	NanoViricides, Inc.
	 	1 Controls Drive
	 	Shelton, CT 06484

 

or to such other address as any party may have
furnished to the other in writing in accordance herewith, except that notices of changes of address shall be effective upon receipt.

 

20.       Waiver

The observation or performance of any condition
or obligation imposed upon the Employee hereunder may be waived only upon the written consent of the Board of Directorsof the Company.
Such waiver shall be limited to the terms thereof and shall not constitute a waiver of any other condition or obligation of the
Employee under this Agreement.

 

21.       Assignment

Neither party shall have the right to assign
any rights or obligations under this Agreement without the prior written approval of the other party.

 

    	 	Page 10 of 11 
	 

     

    

 

22.       Headings

The headings have been inserted for convenience
only and are not to be considered when construing the provisions of this Agreement.

 

23.       Counterparts

The parties may execute this Agreement in multiple
counterparts, each of which constitutes an original as against the party that signed it, and all of which together constitute one
agreement. This Agreement is effective upon delivery of one executed counterpart from each party to the other parties. The signatures
of all parties need not appear on the same counterpart. The delivery of signed counterparts by facsimile or email transmission
that includes a copy of the sending party’s signature is as effective as signing and delivering the counterpart in person.

 

 

IN WITNESS WHEREOF, the parties have executed
this Agreement as of the date and year first written upon.

 

 

	 	For NanoViricides, Inc.
	 	 	 
	 	 	 
	 	/s/	 
	 	By	 
	 	Duly authorized	 
	 	 	 
	 	 	 
	 	For Employee	 
	 	 	 
	 	 	 
	 	/s/	 

 

 

    	 	Page 11 of 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}]]